Human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
Tax	B-protein
activation	O
of	O
NF-kappa	B-protein
B/Rel	I-protein
involves	O
phosphorylation	O
and	O
degradation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
and	O
RelA	B-protein
(	O
p65	B-protein
)	O
-mediated	O
induction	O
of	O
the	O
c-rel	B-DNA
gene	I-DNA
.	O

The	O
tax	O
gene	O
product	O
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
is	O
a	O
potent	O
transcriptional	B-protein
activator	I-protein
that	O
both	O
stimulates	O
viral	O
gene	O
expression	O
and	O
activates	O
an	O
array	O
of	O
cellular	B-DNA
genes	I-DNA
involved	O
in	O
T-cell	B-cell_type
growth	O
.	O

Tax	O
acts	O
indirectly	O
by	O
inducing	O
or	O
modifying	O
the	O
action	O
of	O
various	O
host	O
transcription	B-protein
factors	I-protein
,	O
including	O
members	O
of	O
the	O
NF-kappa	B-protein
B/Rel	I-protein
family	I-protein
of	O
enhancer-binding	B-protein
proteins	I-protein
.	O

In	O
resting	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
many	O
of	O
these	O
NF-kappa	B-protein
B/Rel	I-protein
factors	I-protein
are	O
sequestered	O
in	O
the	O
cytoplasm	O
by	O
various	O
ankyrin-rich	B-protein
inhibitory	I-protein
proteins	I-protein
,	O
including	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

HTLV-I	B-protein
Tax	I-protein
expression	O
leads	O
to	O
the	O
constitutive	O
nuclear	O
expression	O
of	O
biologically	O
active	O
NF-kappa	B-protein
B	I-protein
and	O
c-Rel	B-protein
complexes	I-protein
;	O
however	O
,	O
the	O
biochemical	O
mechanism	O
(	O
s	O
)	O
underlying	O
this	O
response	O
remains	O
poorly	O
understood	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
Tax	B-protein
-stimulated	O
nuclear	O
expression	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
both	O
HTLV-I-infected	B-cell_line
and	I-cell_line
Tax-transfected	I-cell_line
human	I-cell_line
T	I-cell_line
cells	I-cell_line
is	O
associated	O
with	O
the	O
phosphorylation	O
and	O
rapid	O
proteolytic	O
degradation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

In	O
contrast	O
to	O
prior	O
in	O
vitro	O
studies	O
,	O
at	O
least	O
a	O
fraction	O
of	O
the	O
phosphorylated	O
form	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
remains	O
physically	O
associated	O
with	O
the	O
NF-kappa	B-protein
B	I-protein
complex	I-protein
in	O
vivo	O
but	O
is	O
subject	O
to	O
rapid	O
degradation	O
,	O
thereby	O
promoting	O
the	O
nuclear	O
translocation	O
of	O
the	O
active	O
NF-kappa	B-protein
B	I-protein
complex	I-protein
.	O

We	O
further	O
demonstrate	O
that	O
Tax	B-protein
induction	O
of	O
nuclear	O
c-Rel	B-protein
expression	O
is	O
activated	O
by	O
the	O
RelA	B-protein
(	O
p65	B-protein
)	O
subunit	O
of	O
NF-kappa	B-protein
B	I-protein
,	O
which	O
activates	O
transcription	O
of	O
the	O
c-rel	B-DNA
gene	I-DNA
through	O
an	O
intrinsic	O
kappa	B-DNA
B	I-DNA
enhancer	I-DNA
element	I-DNA
.	O

In	O
normal	O
cells	O
,	O
the	O
subsequent	O
accumulation	O
of	O
nuclear	B-protein
c-Rel	I-protein
acts	O
to	O
inhibit	O
its	O
own	O
continued	O
production	O
,	O
indicating	O
the	O
presence	O
of	O
an	O
autoregulatory	O
loop	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
Nov.	NULL
1994	NULL
,	NULL
p.	NULL
7377-7384	NULL
0270-7306/94/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1994	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

14	NULL
,	NULL
No	NULL
.	NULL

11	NULL
Human	NULL
T-Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
I	NULL
Tax	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
Involves	NULL
Phosphorylation	NULL
and	NULL
Degradation	NULL
of	NULL
IxBa	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
-Mediated	NULL
Induction	NULL
of	NULL
the	NULL
c-re/	NULL
Gene	NULL
SHAOQ-CONG	NULL
SUN	NULL
,	NULL
JOHN	NULL
ELWOOD	NULL
,	NULL
CHRISTOPHE	NULL
BERAUD	NULL
,	NULL
anp	NULL
WARNER	NULL
C.	NULL
GREENE*	NULL
Gladstone	NULL
Institute	NULL
of	NULL
Virology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
and	NULL
San	NULL
Francisco	NULL
General	NULL
Hospital	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
California	NULL
94141-9100	NULL
Received	NULL
9	NULL
June	NULL
1994/Returned	NULL
for	NULL
modification	NULL
14	NULL
July	NULL
1994/Accepted	NULL
1	NULL
August	NULL
1994	NULL
The	NULL
tax	NULL
gene	NULL
product	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
is	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
that	NULL
both	NULL
stimulates	NULL
viral	NULL
gene	NULL
expression	NULL
and	NULL
activates	NULL
an	NULL
array	NULL
of	NULL
cellular	NULL
genes	NULL
involved	NULL
in	NULL
T-cell	NULL
growth	NULL
.	NULL

Tax	NULL
acts	NULL
indirectly	NULL
by	NULL
inducing	NULL
or	NULL
modifying	NULL
the	NULL
action	NULL
of	NULL
various	NULL
host	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
of	NULL
enhancer-binding	NULL
proteins	NULL
.	NULL

In	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
many	NULL
of	NULL
these	NULL
NF-B/Rel	NULL
factors	NULL
are	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
various	NULL
ankyrin-rich	NULL
inhibitory	NULL
proteins	NULL
,	NULL
including	NULL
IxBa	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
expression	NULL
leads	NULL
to	NULL
the	NULL
constitutive	NULL
nuclear	NULL
expression	NULL
of	NULL
biologically	NULL
active	NULL
NF-B	NULL
and	NULL
c-Rel	NULL
complexes	NULL
;	NULL
however	NULL
,	NULL
the	NULL
biochemical	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
underlying	NULL
this	NULL
response	NULL
remains	NULL
poorly	NULL
understood	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
Tax-stimulated	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-B	NULL
in	NULL
both	NULL
HTLV-I-infected	NULL
and	NULL
Tax-transfected	NULL
human	NULL
T	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
phosphorylation	NULL
and	NULL
rapid	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
prior	NULL
in	NULL
vitro	NULL
studies	NULL
,	NULL
at	NULL
least	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
remains	NULL
physically	NULL
associated	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
in	NULL
vivo	NULL
but	NULL
is	NULL
subject	NULL
to	NULL
rapid	NULL
degradation	NULL
,	NULL
thereby	NULL
promoting	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
active	NULL
NF-xB	NULL
complex	NULL
.	NULL

We	NULL
further	NULL
demonstrate	NULL
that	NULL
Tax	NULL
induction	NULL
of	NULL
nuclear	NULL
c-Rel	NULL
expression	NULL
is	NULL
activated	NULL
by	NULL
the	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
subunit	NULL
of	NULL
NF-B	NULL
,	NULL
which	NULL
activates	NULL
transcription	NULL
of	NULL
the	NULL
c-re/	NULL
gene	NULL
through	NULL
an	NULL
intrinsic	NULL
xB	NULL
enhancer	NULL
element	NULL
.	NULL

In	NULL
normal	NULL
cells	NULL
,	NULL
the	NULL
subsequent	NULL
accumulation	NULL
of	NULL
nuclear	NULL
c-Rel	NULL
acts	NULL
to	NULL
inhibit	NULL
its	NULL
own	NULL
continued	NULL
production	NULL
,	NULL
indicating	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
autoregulatory	NULL
loop	NULL
.	NULL

However	NULL
,	NULL
the	NULL
pathologic	NULL
action	NULL
of	NULL
HTLV-I	NULL
Tax	NULL
leads	NULL
to	NULL
the	NULL
deregulated	NULL
and	NULL
sustained	NULL
nuclear	NULL
expression	NULL
of	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
c-Rel	NULL
,	NULL
a	NULL
response	NULL
that	NULL
may	NULL
contribute	NULL
to	NULL
HTLV-I-induced	NULL
T-cell	NULL
transformation	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
is	NULL
a	NULL
type	NULL
C	NULL
retrovirus	NULL
that	NULL
primarily	NULL
produces	NULL
disease	NULL
within	NULL
the	NULL
CD4*	NULL
subset	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
for	NULL
recent	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
27	NULL
and	NULL
88	NULL
)	NULL
.	NULL

Infection	NULL
with	NULL
HTLV-I	NULL
has	NULL
been	NULL
etiologically	NULL
linked	NULL
with	NULL
an	NULL
aggressive	NULL
CD4	NULL
*	NULL
T-cell	NULL
malignancy	NULL
termed	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
61	NULL
,	NULL
89	NULL
)	NULL
and	NULL
several	NULL
different	NULL
nonmalignant	NULL
diseases	NULL
(	NULL
27	NULL
,	NULL
88	NULL
)	NULL
,	NULL
including	NULL
a	NULL
chronic	NULL
neurodegenerative	NULL
syndrome	NULL
termed	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
(	NULL
30	NULL
)	NULL
or	NULL
HTLV-I-associated	NULL
myelopathy	NULL
(	NULL
60	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
precise	NULL
mechanism	NULL
by	NULL
which	NULL
HTLV-I	NULL
transforms	NULL
human	NULL
T	NULL
cells	NULL
remains	NULL
unclear	NULL
,	NULL
the	NULL
HTLV-I	NULL
transactivator	NULL
protein	NULL
,	NULL
Tax	NULL
,	NULL
likely	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
.	NULL

Indeed	NULL
,	NULL
Tax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
possess	NULL
transforming	NULL
potential	NULL
both	NULL
in	NULL
cultured	NULL
cells	NULL
(	NULL
62	NULL
,	NULL
75	NULL
,	NULL
82	NULL
)	NULL
and	NULL
in	NULL
transgenic	NULL
mice	NULL
(	NULL
39	NULL
,	NULL
57	NULL
)	NULL
.	NULL

Tax	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
that	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
all	NULL
viral	NULL
genes	NULL
controlled	NULL
by	NULL
the	NULL
HTLV-I	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
(	NULL
21	NULL
,	NULL
76	NULL
)	NULL
as	NULL
well	NULL
as	NULL
various	NULL
cellular	NULL
genes	NULL
(	NULL
1	NULL
,	NULL
24	NULL
,	NULL
28	NULL
,	NULL
44	NULL
,	NULL
51	NULL
,	NULL
55	NULL
,	NULL
73	NULL
)	NULL
,	NULL
many	NULL
of	NULL
which	NULL
are	NULL
involved	NULL
in	NULL
T-cell	NULL
activation	NULL
and	NULL
growth	NULL
.	NULL

These	NULL
latter	NULL
cellular	NULL
genes	NULL
include	NULL
the	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
gene	NULL
(	NULL
51	NULL
,	NULL
73	NULL
)	NULL
and	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
alpha	NULL
chain	NULL
of	NULL
IL-2	NULL
receptor	NULL
(	NULL
IL-2Ra	NULL
)	NULL
(	NULL
24	NULL
,	NULL
44	NULL
,	NULL
73	NULL
)	NULL
.	NULL

The	NULL
deregulated	NULL
expression	NULL
of	NULL
these	NULL
growth-related	NULL
cellular	NULL
genes	NULL
induced	NULL
by	NULL
Tax	NULL
likely	NULL
contributes	NULL
to	NULL
the	NULL
poly-clonal	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
observed	NULL
early	NULL
after	NULL
HTLV-I	NULL
infection	NULL
(	NULL
34	NULL
)	NULL
.	NULL

This	NULL
proliferative	NULL
process	NULL
may	NULL
in	NULL
turn	NULL
facilitate	NULL
the	NULL
occurrence	NULL
of	NULL
subsequent	NULL
undefined	NULL
genetic	NULL
events	NULL
that	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Gladstone	NULL
Institute	NULL
of	NULL
Virology	NULL
and	NULL
Immunology	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
419100	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94141-9100	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
415	NULL
)	NULL
826-7500	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
415	NULL
)	NULL
826-1817	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
Warner_Greene	NULL
@	NULL
quickmail.ucsf.edu	NULL
.	NULL

7377	NULL
complete	NULL
the	NULL
transformation	NULL
process	NULL
leading	NULL
clinically	NULL
to	NULL
the	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Tax	NULL
does	NULL
not	NULL
bind	NULL
directly	NULL
to	NULL
DNA	NULL
.	NULL

Rather	NULL
,	NULL
Tax	NULL
appears	NULL
to	NULL
alter	NULL
the	NULL
target	NULL
gene	NULL
expression	NULL
in	NULL
a	NULL
more	NULL
indirect	NULL
manner	NULL
by	NULL
modulating	NULL
the	NULL
activity	NULL
or	NULL
expression	NULL
of	NULL
specific	NULL
host	NULL
transcription	NULL
factors	NULL
(	NULL
3	NULL
,	NULL
35	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Tax	NULL
activates	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
by	NULL
physical	NULL
interaction	NULL
with	NULL
HEB-1	NULL
or	NULL
the	NULL
CREB/ATF	NULL
family	NULL
of	NULL
proteins	NULL
,	NULL
which	NULL
specifically	NULL
bind	NULL
to	NULL
the	NULL
21-bp	NULL
repeats	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
(	NULL
15	NULL
,	NULL
81	NULL
,	NULL
90	NULL
,	NULL
91	NULL
)	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
suggests	NULL
that	NULL
Tax	NULL
may	NULL
also	NULL
act	NULL
by	NULL
enhancing	NULL
the	NULL
dimerization	NULL
and	NULL
subsequent	NULL
binding	NULL
of	NULL
various	NULL
CREB	NULL
factors	NULL
(	NULL
84	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
IL-2Ra	NULL
genes	NULL
by	NULL
Tax	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
nuclear	NULL
expression	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
11	NULL
,	NULL
23	NULL
,	NULL
43	NULL
,	NULL
65	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
includes	NULL
the	NULL
p50	NULL
and	NULL
RelA	NULL
(	NULL
previously	NULL
termed	NULL
p65	NULL
)	NULL
subunits	NULL
of	NULL
the	NULL
proto-typical	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
(	NULL
8	NULL
,	NULL
12	NULL
,	NULL
17	NULL
,	NULL
32	NULL
,	NULL
47	NULL
,	NULL
53	NULL
,	NULL
59	NULL
,	NULL
66	NULL
,	NULL
72	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
18	NULL
,	NULL
58	NULL
,	NULL
68	NULL
)	NULL
,	NULL
the	NULL
viral	NULL
oncoprotein	NULL
v-Rel	NULL
(	NULL
77	NULL
,	NULL
87	NULL
)	NULL
,	NULL
the	NULL
cellular	NULL
factor	NULL
c-Rel	NULL
(	NULL
20	NULL
)	NULL
,	NULL
the	NULL
dorsal	NULL
gene	NULL
product	NULL
of	NULL
Drosophila	NULL
melanogaster	NULL
(	NULL
78	NULL
)	NULL
,	NULL
and	NULL
a	NULL
number	NULL
of	NULL
other	NULL
structurally	NULL
related	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
most	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
are	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
as	NULL
latent	NULL
precursors	NULL
by	NULL
a	NULL
family	NULL
of	NULL
ankyrin-rich	NULL
inhibitory	NULL
proteins	NULL
that	NULL
include	NULL
IxBa	NULL
(	NULL
5-7	NULL
,	NULL
14	NULL
,	NULL
29	NULL
,	NULL
37	NULL
)	NULL
,	NULL
p105	NULL
(	NULL
product	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB1	NULL
gene	NULL
[	NULL
52	NULL
,	NULL
56	NULL
,	NULL
64	NULL
]	NULL
)	NULL
,	NULL
and	NULL
p100	NULL
(	NULL
product	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B2	NULL
gene	NULL
[	NULL
52	NULL
,	NULL
56	NULL
,	NULL
80	NULL
]	NULL
)	NULL
.	NULL

IxBa	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
major	NULL
regulatory	NULL
role	NULL
in	NULL
governing	NULL
the	NULL
immediate-early	NULL
expression	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50/	NULL
RelA	NULL
heterodimer	NULL
that	NULL
accompanies	NULL
cellular	NULL
activation	NULL
.	NULL

Specifically	NULL
,	NULL
such	NULL
cellular	NULL
activation	NULL
leads	NULL
to	NULL
the	NULL
rapid	NULL
proteolytic	NULL
degradation	NULL
of	NULL
this	NULL
cytoplasmic	NULL
inhibitor	NULL
,	NULL
a	NULL
process	NULL
which	NULL
in	NULL
turn	NULL
promotes	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
heterodimer	NULL
(	NULL
13	NULL
,	NULL
19	NULL
,	NULL
22	NULL
,	NULL
38	NULL
,	NULL
63	NULL
,	NULL
79	NULL
)	NULL
.	NULL

Although	NULL
small	NULL
amounts	NULL
of	NULL
7378	NULL
SUN	NULL
ET	NULL
AL	NULL
.	NULL

the	NULL
c-Rel	NULL
protein	NULL
are	NULL
similarly	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
predominant	NULL
portion	NULL
of	NULL
nuclear	NULL
c-Rel	NULL
expression	NULL
is	NULL
the	NULL
result	NULL
of	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
and	NULL
thus	NULL
temporally	NULL
delayed	NULL
compared	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
54	NULL
)	NULL
.	NULL

At	NULL
present	NULL
,	NULL
the	NULL
precise	NULL
mechanism	NULL
by	NULL
which	NULL
c-Rel	NULL
protein	NULL
expression	NULL
is	NULL
induced	NULL
is	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

Similarly	NULL
,	NULL
although	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
protein	NULL
is	NULL
known	NULL
to	NULL
strongly	NULL
activate	NULL
nuclear	NULL
expression	NULL
of	NULL
both	NULL
NF-kB	NULL
and	NULL
c-Rel	NULL
(	NULL
3	NULL
,	NULL
74	NULL
)	NULL
,	NULL
the	NULL
underlying	NULL
mechanism	NULL
by	NULL
which	NULL
Tax	NULL
produces	NULL
these	NULL
effects	NULL
remains	NULL
unclear	NULL
.	NULL

Tax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
physically	NULL
associate	NULL
with	NULL
p105	NULL
(	NULL
40	NULL
)	NULL
and	NULL
even	NULL
more	NULL
strongly	NULL
with	NULL
p100	NULL
(	NULL
16	NULL
,	NULL
49	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
our	NULL
hands	NULL
the	NULL
interaction	NULL
of	NULL
p100	NULL
with	NULL
Tax	NULL
leads	NULL
to	NULL
an	NULL
inhibition	NULL
of	NULL
Tax-mediated	NULL
transactivation	NULL
(	NULL
16	NULL
)	NULL
rather	NULL
than	NULL
participating	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
nuclear	NULL
transcription	NULL
factor	NULL
expression	NULL
by	NULL
promoting	NULL
the	NULL
cleavage	NULL
of	NULL
p100	NULL
to	NULL
p52	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Watanabe	NULL
and	NULL
colleagues	NULL
have	NULL
recently	NULL
proposed	NULL
that	NULL
Tax	NULL
stimulates	NULL
the	NULL
release	NULL
of	NULL
p105	NULL
from	NULL
p50	NULL
and	NULL
RelA	NULL
,	NULL
thereby	NULL
allowing	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
(	NULL
86	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
both	NULL
HTLV-I-infected	NULL
and	NULL
Tax-transfected	NULL
T	NULL
cells	NULL
involves	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
«	NULL
.	NULL

Although	NULL
the	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
remains	NULL
physically	NULL
associated	NULL
with	NULL
NF-kB	NULL
,	NULL
this	NULL
modified	NULL
inhibitor	NULL
is	NULL
targeted	NULL
for	NULL
rapid	NULL
degradation	NULL
,	NULL
thereby	NULL
allowing	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

We	NULL
further	NULL
show	NULL
that	NULL
the	NULL
rapidly	NULL
induced	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-kB	NULL
triggers	NULL
transcription	NULL
of	NULL
the	NULL
c-re/	NULL
proto-oncogene	NULL
,	NULL
through	NULL
a	NULL
functional	NULL
5	NULL
kB	NULL
enhancer	NULL
element	NULL
.	NULL

These	NULL
findings	NULL
demonstrate	NULL
that	NULL
one	NULL
Rel-related	NULL
protein	NULL
can	NULL
control	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
second	NULL
Rel	NULL
protein	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
accumulation	NULL
of	NULL
c-Rel	NULL
normally	NULL
serves	NULL
to	NULL
inhibit	NULL
its	NULL
own	NULL
further	NULL
production	NULL
;	NULL
however	NULL
,	NULL
HTLV-I	NULL
Tax	NULL
is	NULL
capable	NULL
of	NULL
overriding	NULL
this	NULL
feedback	NULL
inhibitory	NULL
loop	NULL
,	NULL
leading	NULL
to	NULL
sustained	NULL
high-level	NULL
nuclear	NULL
expression	NULL
of	NULL
both	NULL
NF-kB	NULL
and	NULL
c-Rel	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

The	NULL
HTLV-I-infected	NULL
T-cell	NULL
lines	NULL
C8166	NULL
,	NULL
HUT	NULL
102	NULL
,	NULL
and	NULL
K3T	NULL
as	NULL
well	NULL
as	NULL
the	NULL
noninfected	NULL
Jurkat	NULL
leukemic	NULL
T	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
u-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Jurkat-Tax	NULL
and	NULL
Jurkat-anti-Tax	NULL
cells	NULL
(	NULL
85	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
containing	NULL
800	NULL
pg	NULL
of	NULL
the	NULL
antibiotic	NULL
G418	NULL
per	NULL
ml	NULL
to	NULL
select	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
neomycin	NULL
resistance	NULL
gene	NULL
.	NULL

F9	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
Iscove	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glu-tamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Immunoblotting	NULL
,	NULL
immunoprecipitation	NULL
,	NULL
and	NULL
electrophoresis	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

The	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
and	NULL
noninfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
at	NULL
800	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Subcellular	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
70	NULL
)	NULL
except	NULL
that	NULL
the	NULL
cell	NULL
lysis	NULL
buffer	NULL
was	NULL
supplemented	NULL
with	NULL
various	NULL
phosphatase	NULL
inhibitors	NULL
,	NULL
including	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
0.1	NULL
mM	NULL
Na	NULL
,	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
M	NULL
ZnCl	NULL
,	NULL
and	NULL
10	NULL
wM	NULL
sodium	NULL
molybdate	NULL
(	NULL
80	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
extracts	NULL
(	NULL
500	NULL
ug	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
the	NULL
immunoprecipitated	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
as	NULL
described	NULL
below	NULL
.	NULL

For	NULL
immunoblotting	NULL
analyses	NULL
,	NULL
protein	NULL
samples	NULL
were	NULL
frac-tionated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electro-phoresis	NULL
,	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
mem-branes	NULL
,	NULL
and	NULL
then	NULL
analyzed	NULL
for	NULL
immunoreactivity	NULL
with	NULL
various	NULL
antipeptide	NULL
antisera	NULL
,	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

For	NULL
phosphatase	NULL
treatment	NULL
,	NULL
the	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
calf	NULL
intestinal	NULL
alkaline	NULL
phos-	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

phatase	NULL
(	NULL
0.15	NULL
U/pg	NULL
of	NULL
extract	NULL
)	NULL
or	NULL
incipient	NULL
buffer	NULL
controls	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
prior	NULL
to	NULL
immunoblotting	NULL
analysis	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
by	NULL
incubating	NULL
the	NULL
nuclear	NULL
extracts	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
with	NULL
a	NULL
°°P-radiolabeled	NULL
high-affinity	NULL
palindromic	NULL
kB	NULL
probe	NULL
,	NULL
xB-pd	NULL
(	NULL
coding	NULL
strand	NULL
sequence	NULL
was	NULL
5-CAACGGCAG	NULL
GGGAATTCCCCTCTCCIT-3	NULL
'	NULL
)	NULL
,	NULL
and	NULL
then	NULL
resolving	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
on	NULL
native	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Plasmids	NULL
,	NULL
transient	NULL
transfection	NULL
,	NULL
and	NULL
luciferase	NULL
assays	NULL
.	NULL

All	NULL
cDNAs	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
pCMV4	NULL
expression	NULL
vector	NULL
generously	NULL
provided	NULL
by	NULL
M.	NULL
Stinski	NULL
and	NULL
D.	NULL
Russell	NULL
(	NULL
2	NULL
)	NULL
.	NULL

N-	NULL
and	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
of	NULL
RelA	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
using	NULL
specific	NULL
primers	NULL
and	NULL
the	NULL
full-length	NULL
RelA	NULL
cDNA	NULL
as	NULL
a	NULL
template	NULL
(	NULL
29	NULL
)	NULL
.	NULL

p65	NULL
(	NULL
1-312	NULL
)	NULL
corresponds	NULL
to	NULL
a	NULL
C-terminal	NULL
truncation	NULL
mutant	NULL
of	NULL
RelA	NULL
that	NULL
retains	NULL
the	NULL
N-terminal	NULL
Rel	NULL
homology	NULL
domain	NULL
but	NULL
lacks	NULL
the	NULL
entire	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
RelA	NULL
.	NULL

This	NULL
Rel	NULL
mutant	NULL
functions	NULL
as	NULL
a	NULL
transdominant	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

p65	NULL
(	NULL
41-551	NULL
)	NULL
is	NULL
an	NULL
N-terminal	NULL
truncation	NULL
mutant	NULL
that	NULL
lacks	NULL
the	NULL
N-terminal	NULL
40	NULL
amino	NULL
acids	NULL
and	NULL
is	NULL
defective	NULL
in	NULL
DNA	NULL
binding	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
plasmids	NULL
pLuc-97	NULL
and	NULL
pLuc-23	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
the	NULL
late	NULL
Howard	NULL
Temin	NULL
)	NULL
were	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
chicken	NULL
c-re/	NULL
promoter	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
36	NULL
)	NULL
.	NULL

pLuc-97	NULL
retains	NULL
a	NULL
«	NULL
B	NULL
enhancer	NULL
element	NULL
,	NULL
GGGAAATTCCC	NULL
,	NULL
located	NULL
at	NULL
-28	NULL
which	NULL
is	NULL
partially	NULL
deleted	NULL
in	NULL
the	NULL
ELuC-23	NULL
plasmid	NULL
.	NULL

Jurkat	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
by	NULL
using	NULL
DEAE-dextran	NULL
(	NULL
42	NULL
)	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
pLuc-97	NULL
or	NULL
pLuc-23	NULL
together	NULL
with	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
fax	NULL
or	NULL
transdominant	NULL
rel4	NULL
cDNA	NULL
expression	NULL
vector	NULL
.	NULL

F9	NULL
cells	NULL
were	NULL
seeded	NULL
onto	NULL
0.1	NULL
%	NULL
gelatin-treated	NULL
,	NULL
six-well	NULL
plates	NULL
(	NULL
3	NULL
%	NULL
10°	NULL
cells	NULL
per	NULL
well	NULL
)	NULL
1	NULL
day	NULL
before	NULL
transfection	NULL
.	NULL

pLuc-97	NULL
(	NULL
0.5	NULL
pg	NULL
)	NULL
and	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
the	NULL
various	NULL
cDNA	NULL
expression	NULL
vectors	NULL
were	NULL
transfected	NULL
by	NULL
using	NULL
the	NULL
Lipo-fectamine	NULL
reagent	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
normalized	NULL
for	NULL
protein	NULL
recovery	NULL
(	NULL
Bio-Rad	NULL
)	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
(	NULL
Pro-mega	NULL
)	NULL
40	NULL
to	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

RESULTS	NULL
HTLV-I	NULL
Tax	NULL
expression	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
constitutive	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
and	NULL
sustained	NULL
nuclear	NULL
expression	NULL
of	NULL
RelA	NULL
and	NULL
c-Rel	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
IxBa	NULL
protein	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
extracts	NULL
from	NULL
long-term	NULL
HTLV-T-infected	NULL
T-cell	NULL
lines	NULL
(	NULL
C8166	NULL
,	NULL
HUT1O2	NULL
,	NULL
and	NULL
K3T	NULL
)	NULL
or	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
either	NULL
a	NULL
functional	NULL
sense	NULL
(	NULL
Jurkat-Tax	NULL
)	NULL
or	NULL
nonfunctional	NULL
antisense	NULL
(	NULL
Jurkat-anti-Tax	NULL
)	NULL
tax	NULL
cDNA	NULL
expression	NULL
plasmid	NULL
(	NULL
85	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

In	NULL
both	NULL
Jurkat-anti-Tax	NULL
cells	NULL
and	NULL
control	NULL
untransfected	NULL
parental	NULL
Jurkat	NULL
cells	NULL
,	NULL
only	NULL
a	NULL
single	NULL
37-kDa	NULL
form	NULL
of	NULL
IxBa	NULL
was	NULL
detected	NULL
with	NULL
an	NULL
anti-IxBa	NULL
antiserum	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
second	NULL
,	NULL
more	NULL
slowly	NULL
migrating	NULL
IxBa	NULL
species	NULL
was	NULL
present	NULL
in	NULL
each	NULL
of	NULL
the	NULL
Tax-expressing	NULL
HTLV-I	NULL
cell	NULL
lines	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
and	NULL
in	NULL
smaller	NULL
amounts	NULL
in	NULL
the	NULL
Jurkat-Tax	NULL
cells	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
this	NULL
apparently	NULL
larger	NULL
IxBa	NULL
species	NULL
was	NULL
correlated	NULL
not	NULL
only	NULL
with	NULL
Tax	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
but	NULL
also	NULL
with	NULL
nuclear	NULL
expression	NULL
of	NULL
DNA-binding	NULL
activity	NULL
,	NULL
as	NULL
measured	NULL
in	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
slower	NULL
mobility	NULL
of	NULL
this	NULL
IxBa	NULL
species	NULL
was	NULL
apparently	NULL
the	NULL
result	NULL
of	NULL
phosphorylation	NULL
,	NULL
as	NULL
this	NULL
form	NULL
could	NULL
be	NULL
completely	NULL
converted	NULL
to	NULL
the	NULL
faster-migrating	NULL
37-kDa	NULL
species	NULL
by	NULL
in	NULL
vitro	NULL
treatment	NULL
with	NULL
calf	NULL
intestinal	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
but	NULL
not	NULL
by	NULL
the	NULL
incipient	NULL
buffer	NULL
control	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Parallel	NULL
immunoblotting	NULL
studies	NULL
of	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
fractions	NULL
from	NULL
these	NULL
cells	NULL
revealed	NULL
that	NULL
both	NULL
c-Rel	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
and	NULL
the	NULL
RelA	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
were	NULL
constitutively	NULL
expressed	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
these	NULL
Tax-expressing	NULL
cells	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
parental	NULL
Jurkat	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
VoL	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
A.	NULL
D.	NULL
1341	NULL
messes	NULL
tell	NULL
kC	NULL
‘	NULL
L	NULL
Lok	NULL
B	NULL
.	NULL

&	NULL
0	NULL
)	NULL
”	NULL
;	NULL
0	NULL
)	NULL
%	NULL
o	NULL
»	NULL
-~	NULL
*	NULL
``	NULL
%	NULL
Buffer	NULL
CIP	NULL
--	NULL
-	NULL
Complexes	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Correlation	NULL
between	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
and	NULL
expression	NULL
of	NULL
nuclear	NULL
NF-kB/Rel	NULL
DNA-binding	NULL
activity	NULL
in	NULL
HTLV-I-infected	NULL
or	NULL
Tax-expressing	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
A	NULL
modified	NULL
form	NULL
of	NULL
IxBa	NULL
is	NULL
present	NULL
in	NULL
Tax-expressing	NULL
cells	NULL
.	NULL

Cytoplasmic	NULL
(	NULL
A	NULL
)	NULL
or	NULL
whole-cell	NULL
(	NULL
B	NULL
)	NULL
extracts	NULL
(	NULL
80	NULL
pg	NULL
)	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
indicated	NULL
cells	NULL
and	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
peptide-specific	NULL
antisera	NULL
directed	NULL
against	NULL
either	NULL
the	NULL
C	NULL
terminus	NULL
(	NULL
amino	NULL
acids	NULL
289	NULL
to	NULL
317	NULL
)	NULL
of	NULL
IxBa	NULL
(	NULL
A	NULL
)	NULL
or	NULL
the	NULL
C	NULL
terminus	NULL
(	NULL
amino	NULL
acids	NULL
321	NULL
to	NULL
353	NULL
)	NULL
of	NULL
Tax	NULL
(	NULL
B	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Nuclear	NULL
NF-kB/Re	NULL
!	NULL

DNA-binding	NULL
activity	NULL
is	NULL
correlated	NULL
with	NULL
Tax	NULL
expression	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
modified	NULL
form	NULL
of	NULL
IxBa	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
DNA-binding	NULL
activity	NULL
,	NULL
using	NULL
a	NULL
*°P-radiolabeled	NULL
«	NULL
kB	NULL
probe	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
The	NULL
modified	NULL
form	NULL
of	NULL
IxBa	NULL
is	NULL
phosphorylated	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
from	NULL
C8166	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
or	NULL
HUT1O02	NULL
cells	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
of	NULL
calf	NULL
intestinal	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
CIP	NULL
)	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
analysis	NULL
with	NULL
anti-IxBa	NULL
.	NULL

Jurkat-anti-Tax	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
cells	NULL
,	NULL
these	NULL
factors	NULL
were	NULL
principally	NULL
confined	NULL
to	NULL
the	NULL
cytoplasm	NULL
.	NULL

Additionally	NULL
,	NULL
on	NULL
a	NULL
whole-cell	NULL
basis	NULL
,	NULL
the	NULL
overall	NULL
level	NULL
of	NULL
c-Rel	NULL
expression	NULL
appeared	NULL
slightly	NULL
greater	NULL
in	NULL
the	NULL
Tax-expressing	NULL
cells	NULL
than	NULL
in	NULL
the	NULL
Jurkat	NULL
cell	NULL
controls	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Phosphorylated	NULL
IxBa	NULL
remains	NULL
associated	NULL
with	NULL
RelA	NULL
but	NULL
is	NULL
subject	NULL
to	NULL
rapid	NULL
degradation	NULL
.	NULL

To	NULL
further	NULL
explore	NULL
the	NULL
biochemical	NULL
basis	NULL
for	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
c-Rel	NULL
in	NULL
the	NULL
HTLV-I-infected	NULL
cells	NULL
,	NULL
studies	NULL
were	NULL
performed	NULL
to	NULL
test	NULL
whether	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
resulted	NULL
in	NULL
its	NULL
physical	NULL
separation	NULL
from	NULL
RelA	NULL
and	NULL
c-Rel	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

In	NULL
surprising	NULL
contrast	NULL
to	NULL
the	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1011	NULL
12	NULL
fof	NULL
24	NULL
)	NULL
Fi	NULL
Ledirepeatcd	NULL
s	NULL
f	NULL
)	NULL
1	NULL
A	NULL
€	NULL
.	NULL

o_	NULL
_	NULL
uo	NULL
dn	NULL
ear	NULL
c-	NULL
age-	NULL
cc	NULL
-	NULL
&	NULL
--	NULL
c-Rel	NULL
B	NULL
=	NULL
e-	NULL
_	NULL
0	NULL
--	NULL
p65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Subcellular	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
c-Rel	NULL
and	NULL
RelA	NULL
in	NULL
various	NULL
HTLV-L-infected	NULL
cells	NULL
and	NULL
Jurkat-Tax	NULL
or	NULL
Jurkat	NULL
anti-Tax	NULL
cell	NULL
lines	NULL
.	NULL

Cytoplasmic	NULL
(	NULL
C	NULL
)	NULL
and	NULL
nuclear	NULL
(	NULL
N	NULL
)	NULL
extracts	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
antisera	NULL
specific	NULL
for	NULL
either	NULL
the	NULL
C	NULL
terminus	NULL
(	NULL
amino	NULL
acids	NULL
573	NULL
to	NULL
587	NULL
)	NULL
of	NULL
c-Rel	NULL
(	NULL
A	NULL
)	NULL
or	NULL
the	NULL
C	NULL
terminus	NULL
(	NULL
amino	NULL
acids	NULL
529	NULL
to	NULL
551	NULL
)	NULL
of	NULL
Rel	NULL
A	NULL
(	NULL
B	NULL
)	NULL
.	NULL

ACTIVATION	NULL
OF	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
BY	NULL
HTLV-I	NULL
Tax	NULL
PROTEIN	NULL
7379	NULL
A	NULL
.	NULL

B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
d	NULL
|	NULL
ss	NULL
4	NULL
.	NULL

1	NULL
e	NULL
IKBu-®	NULL
«	NULL
»	NULL
U	NULL
-IkBo-®	NULL
)	NULL
-	NULL
wars	NULL
-	NULL
>	NULL
®	NULL
4	NULL
%	NULL
--	NULL
IxBa	NULL
epam	NULL
-1	NULL
<	NULL
Bc	NULL
LoL	NULL
A	NULL
to	NULL
Loklkekaklkekokl	NULL
LD	NULL
41.174	NULL
5	NULL
%	NULL
a	NULL
totic	NULL
tt	NULL
,	NULL
**	NULL
**	NULL
%	NULL
*	NULL
an	NULL
.	NULL

3	NULL
.	NULL

5	NULL
A	NULL
z	NULL
*	NULL
ed	NULL
690/	NULL
OS	NULL
6,4/	NULL
Cs1i66	NULL
Jurkat	NULL
+	NULL
+	NULL
CHX	NULL
CHX	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
on	NULL
its	NULL
physical	NULL
association	NULL
with	NULL
Rel	NULL
A	NULL
and	NULL
c-Rel	NULL
and	NULL
subsequent	NULL
intracellular	NULL
survival	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Physical	NULL
association	NULL
of	NULL
phosphorylated	NULL
IxBa	NULL
with	NULL
RelA	NULL
and	NULL
c-Rel	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
from	NULL
HUT102	NULL
cells	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
either	NULL
a	NULL
preimmune	NULL
serum	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
a	NULL
peptide-specific	NULL
antiserum	NULL
recognizing	NULL
IxBa	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
c-Rel	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
resultant	NULL
immunoprecipitates	NULL
were	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
an	NULL
IxBa-specific	NULL
antiserum	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
migration	NULL
of	NULL
IxBa	NULL
and	NULL
its	NULL
phosphorylated	NULL
isoform	NULL
(	NULL
IxBa-P	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Intracellular	NULL
fate	NULL
of	NULL
IxBa	NULL
and	NULL
IxBa-P	NULL
in	NULL
Tax-expressing	NULL
C8166	NULL
and	NULL
Tax-nonexpressing	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

C8166	NULL
cells	NULL
or	NULL
Jurkat	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
intervals	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
analysis	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
IxBa	NULL
and	NULL
IxBa-P	NULL
present	NULL
in	NULL
the	NULL
whole-cell	NULL
extracts	NULL
.	NULL

complete	NULL
release	NULL
of	NULL
IxBa	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
proposed	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
in	NULL
vitro	NULL
phosphorylation	NULL
experiments	NULL
(	NULL
31	NULL
)	NULL
,	NULL
both	NULL
phosphorylated	NULL
and	NULL
nonphosphorylated	NULL
forms	NULL
of	NULL
IxBa	NULL
from	NULL
HUT102	NULL
cells	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
physical	NULL
association	NULL
with	NULL
RelA	NULL
,	NULL
as	NULL
judged	NULL
from	NULL
their	NULL
coimmunoprecipitation	NULL
with	NULL
RelA	NULL
with	NULL
use	NULL
of	NULL
RelA-specific	NULL
antibodies	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
anti-c-Rel	NULL
co-immunoprecipitated	NULL
phosphorylated	NULL
IxBa	NULL
,	NULL
although	NULL
the	NULL
overall	NULL
recovery	NULL
of	NULL
IxBa	NULL
species	NULL
was	NULL
diminished	NULL
with	NULL
the	NULL
anti-c-Rel	NULL
antibody	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
phosphorylation	NULL
of	NULL
I	NULL
«	NULL
xBa	NULL
altered	NULL
its	NULL
intracellular	NULL
survival	NULL
,	NULL
the	NULL
fate	NULL
of	NULL
both	NULL
the	NULL
phosphorylated	NULL
and	NULL
37-kDa	NULL
forms	NULL
of	NULL
IxBa	NULL
was	NULL
examined	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
Tax-expressing	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
to	NULL
block	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
this	NULL
inhibitor	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
of	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
essentially	NULL
no	NULL
change	NULL
in	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
37-kDa	NULL
IxBa	NULL
species	NULL
occurred	NULL
over	NULL
a	NULL
2-h	NULL
period	NULL
following	NULL
CHX	NULL
treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
a	NULL
relatively	NULL
long	NULL
half-life	NULL
(	NULL
t	NULL
,	NULL
,	NULL
,	NULL
>	NULL
120	NULL
min	NULL
)	NULL
for	NULL
this	NULL
unmodified	NULL
form	NULL
of	NULL
IkxBa	NULL
in	NULL
these	NULL
noninfected	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
phosphorylated	NULL
IxBa	NULL
species	NULL
(	NULL
IxBa-P	NULL
)	NULL
present	NULL
in	NULL
the	NULL
Tax-expressing	NULL
C8166	NULL
cells	NULL
proved	NULL
quite	NULL
unstable	NULL
,	NULL
exhibiting	NULL
a	NULL
t	NULL
,	NULL
,	NULL
,	NULL
of	NULL
less	NULL
than	NULL
5	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
,	NULL
upper	NULL
band	NULL
)	NULL
.	NULL

The	NULL
unmodified	NULL
37-kDa	NULL
IxBa	NULL
species	NULL
was	NULL
also	NULL
rapidly	NULL
degraded	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
likely	NULL
reflecting	NULL
ongoing	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
induced	NULL
by	NULL
the	NULL
previously	NULL
synthesized	NULL
Tax	NULL
protein	NULL
that	NULL
remained	NULL
active	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
independent	NULL
experiments	NULL
using	NULL
two	NULL
other	NULL
Tax-expressing	NULL
HTLV	NULL
-I-infected	NULL
T-cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
phosphorylation	NULL
of	NULL
IkxBa	NULL
occurring	NULL
in	NULL
HTLV-I-infected	NULL
cells	NULL
likely	NULL
targets	NULL
this	NULL
inhibitor	NULL
for	NULL
rapid	NULL
intracellular	NULL
degradation	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-B	NULL
nuclear	NULL
expression	NULL
by	NULL
chymotrypsin-type	NULL
protease	NULL
inhibitors	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
blockade	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
various	NULL
types	NULL
of	NULL
proteases	NULL
in	NULL
the	NULL
intracellular	NULL
destabilization	NULL
of	NULL
IxBa	NULL
«	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
different	NULL
protease	NULL
inhibitors	NULL
were	NULL
studied	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
treatment	NULL
of	NULL
Tax-expressing	NULL
C8166	NULL
cells	NULL
for	NULL
4	NULL
h	NULL
with	NULL
the	NULL
chymotrypsin-type	NULL
protease	NULL
inhibitor	NULL
tosylphenylalanine	NULL
chloromethyl	NULL
ketone	NULL
7380	NULL
SUN	NULL
ET	NULL
AL	NULL
.	NULL

FIG	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
chymotrypsin-type	NULL
TPCK	NULL
and	NULL
trypsin-type	NULL
TLCK	NULL
protease	NULL
inhibitors	NULL
on	NULL
nuclear	NULL
NF-	NULL
«	NULL
xB/Rel	NULL
DNA-binding	NULL
activity	NULL
in	NULL
HTLV-L-infected	NULL
T	NULL
cells	NULL
.	NULL

C8166	NULL
cells	NULL
were	NULL
either	NULL
not	NULL
treated	NULL
or	NULL
incubated	NULL
with	NULL
25	NULL
or	NULL
50	NULL
wM	NULL
TPCK	NULL
or	NULL
TLCK	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
after	NULL
which	NULL
nuclear	NULL
NF-	NULL
«	NULL
B/Rel	NULL
DNA-binding	NULL
activity	NULL
was	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
TPCK	NULL
)	NULL
partially	NULL
(	NULL
25	NULL
wM	NULL
)	NULL
or	NULL
completely	NULL
(	NULL
50	NULL
wM	NULL
)	NULL
inhibited	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
trypsin-type	NULL
protease	NULL
inhibitor	NULL
tosyllysine	NULL
chloromethyl	NULL
ketone	NULL
(	NULL
TLCK	NULL
)	NULL
exerted	NULL
no	NULL
significant	NULL
inhibitory	NULL
effects	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
TPCK	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
T-cell	NULL
activation	NULL
by	NULL
blocking	NULL
early	NULL
T-cell	NULL
signaling	NULL
events	NULL
,	NULL
including	NULL
calcium	NULL
mobilization	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
considered	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
protease	NULL
inhibitor	NULL
acts	NULL
by	NULL
inhibiting	NULL
a	NULL
more	NULL
proximal	NULL
signal	NULL
transduction	NULL
event	NULL
leading	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
rather	NULL
than	NULL
simply	NULL
blocking	NULL
subsequent	NULL
protease-mediated	NULL
degradation	NULL
of	NULL
IxBa	NULL
«	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
notion	NULL
,	NULL
incubation	NULL
of	NULL
C8166	NULL
cells	NULL
with	NULL
TPCK	NULL
resulted	NULL
in	NULL
the	NULL
rapid	NULL
disappearance	NULL
of	NULL
phosphorylated	NULL
IxBa	NULL
«	NULL
accompanied	NULL
by	NULL
accumulation	NULL
of	NULL
the	NULL
37-kDa	NULL
nonphosphorylated	NULL
IxBa	NULL
species	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
within	NULL
15	NULL
min	NULL
after	NULL
TPCK	NULL
addition	NULL
,	NULL
almost	NULL
the	NULL
entire	NULL
intracellular	NULL
pool	NULL
of	NULL
IxBa	NULL
corresponded	NULL
to	NULL
the	NULL
unphosphorylated	NULL
37-kDa	NULL
form	NULL
of	NULL
IxBa	NULL
(	NULL
Fig	NULL
.	NULL

SA	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
this	NULL
apparent	NULL
blockade	NULL
of	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
mediated	NULL
by	NULL
TPCK	NULL
in	NULL
turn	NULL
produced	NULL
intracellular	NULL
stabilization	NULL
of	NULL
this	NULL
inhibitor	NULL
,	NULL
CHX	NULL
was	NULL
added	NULL
to	NULL
cells	NULL
preincubated	NULL
with	NULL
TPCK	NULL
for	NULL
1	NULL
min	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
2	NULL
h	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

When	NULL
present	NULL
for	NULL
2	NULL
h	NULL
,	NULL
TPCK	NULL
blocked	NULL
the	NULL
rapid	NULL
degradation	NULL
of	NULL
IkxBa	NULL
seen	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
alone	NULL
(	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
9	NULL
)	NULL
,	NULL
which	NULL
was	NULL
correlated	NULL
with	NULL
conversion	NULL
of	NULL
the	NULL
entire	NULL
IxBa	NULL
pool	NULL
to	NULL
its	NULL
nonphosphorylated	NULL
form	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
its	NULL
inability	NULL
to	NULL
inhibit	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
in	NULL
these	NULL
HTLV-l-infected	NULL
cells	NULL
,	NULL
TLCK	NULL
neither	NULL
inhibited	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
«	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
nor	NULL
prevented	NULL
the	NULL
rapid	NULL
degradation	NULL
of	NULL
this	NULL
inhibitor	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

To	NULL
further	NULL
explore	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
TPCK	NULL
were	NULL
next	NULL
examined	NULL
on	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
-in-duced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
prior	NULL
reports	NULL
(	NULL
13	NULL
,	NULL
80	NULL
)	NULL
,	NULL
TNF-	NULL
«	NULL
transiently	NULL
induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
addition	NULL
of	NULL
TPCK	NULL
for	NULL
5	NULL
min	NULL
prior	NULL
to	NULL
TNF-	NULL
«	NULL
addition	NULL
resulted	NULL
in	NULL
a	NULL
complete	NULL
inhibition	NULL
of	NULL
this	NULL
induced	NULL
phosphorylation	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
while	NULL
addition	NULL
of	NULL
TLCK	NULL
was	NULL
without	NULL
effect	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Similar	NULL
inhibition	NULL
of	NULL
both	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
induced	NULL
by	NULL
Tax	NULL
or	NULL
TNF-	NULL
«	NULL
was	NULL
observed	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
pyrrolidinedithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
a	NULL
free-radical	NULL
scavenger	NULL
and	NULL
metal	NULL
chelator	NULL
previously	NULL
reported	NULL
to	NULL
block	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
are	NULL
most	NULL
consistent	NULL
with	NULL
Tax-	NULL
or	NULL
TNF-	NULL
«	NULL
-induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
serving	NULL
as	NULL
a	NULL
molecular	NULL
trigger	NULL
that	NULL
leads	NULL
to	NULL
the	NULL
subsequent	NULL
rapid	NULL
degradation	NULL
of	NULL
this	NULL
inhibitor	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
c-Rel	NULL
.	NULL

The	NULL
c-rel	NULL
proto-oncogene	NULL
is	NULL
transcriptionally	NULL
induced	NULL
by	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

€	NULL
2	NULL
o	NULL
ors	NULL
225°	NULL
°	NULL
,	NULL
``	NULL
o=	NULL
,	NULL
~R	NULL
.	NULL

~T	NULL
``	NULL
Fo	NULL
,	NULL
*+	NULL
9664-9	NULL
<	NULL
ﬁésob	NULL
.	NULL

*	NULL
%	NULL
c	NULL
B	NULL
.	NULL

$	NULL
s	NULL
5a	NULL
*	NULL
Apaka	NULL
S	NULL
0	NULL
,	NULL
$	NULL
,	NULL
L	NULL
08	NULL
,	NULL
Z	NULL
6	NULL
3	NULL
*	NULL
%	NULL
*~	NULL
,	NULL
``	NULL
%	NULL
``	NULL
*	NULL
,	NULL
TNF-a	NULL
Sasy	NULL
s	NULL
0,5	NULL
,	NULL
``	NULL
z	NULL
,	NULL
's	NULL
*5	NULL
``	NULL
%	NULL
,	NULL
*	NULL
%	NULL
,	NULL
TNF-o+TPCK	NULL
-	NULL
TNF-o+TLCK	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
TPCK	NULL
and	NULL
TLCK	NULL
on	NULL
the	NULL
phosphorylation	NULL
and	NULL
intracellular	NULL
stability	NULL
of	NULL
IxBa	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Effects	NULL
of	NULL
TPCK	NULL
and	NULL
TLCK	NULL
on	NULL
the	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
«	NULL
in	NULL
HTLV-I-infected	NULL
C8166	NULL
cells	NULL
.	NULL

C8166	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
incubated	NULL
with	NULL
50	NULL
wM	NULL
TPCK	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
6	NULL
)	NULL
or	NULL
50	NULL
uM	NULL
TLCK	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
.	NULL

Aliquots	NULL
of	NULL
these	NULL
cells	NULL
were	NULL
further	NULL
incubated	NULL
with	NULL
50	NULL
ug	NULL
of	NULL
CHX	NULL
per	NULL
ml	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
to	NULL
analyze	NULL
IxBa	NULL
survival	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
new	NULL
protein	NULL
synthesis	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
then	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
IxBa	NULL
and	NULL
I	NULL
«	NULL
Ba-P	NULL
by	NULL
immunoblotting	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effects	NULL
of	NULL
TPCK	NULL
and	NULL
TLCK	NULL
on	NULL
TNF-	NULL
«	NULL
-induced	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
or	NULL
cultured	NULL
with	NULL
50	NULL
wM	NULL
TPCK	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
for	NULL
5	NULL
min	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
,	NULL
after	NULL
which	NULL
IxBa	NULL
and	NULL
IxBa-P	NULL
protein	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
.	NULL

RelA	NULL
but	NULL
autorepressed	NULL
by	NULL
the	NULL
c-Rel	NULL
protein	NULL
.	NULL

Prior	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
nuclear	NULL
expression	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
RelA	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
occurs	NULL
within	NULL
minutes	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
induced	NULL
with	NULL
either	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
or	NULL
TNF-	NULL
«	NULL
(	NULL
26	NULL
,	NULL
54	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
nuclear	NULL
expression	NULL
of	NULL
c-Rel	NULL
does	NULL
not	NULL
occur	NULL
until	NULL
several	NULL
hours	NULL
after	NULL
PMA	NULL
stimulation	NULL
and	NULL
appears	NULL
dependent	NULL
upon	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
(	NULL
54	NULL
)	NULL
.	NULL

In	NULL
Tax-expressing	NULL
T	NULL
cells	NULL
,	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
c-Rel	NULL
are	NULL
constitutively	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

In	NULL
view	NULL
of	NULL
these	NULL
findings	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
possibility	NULL
that	NULL
Tax-induced	NULL
c-Rel	NULL
expression	NULL
is	NULL
activated	NULL
by	NULL
NF-kB	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
Tax	NULL
cDNA	NULL
expression	NULL
vector	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
a	NULL
transdominant	NULL
RelA	NULL
mutant	NULL
containing	NULL
only	NULL
a	NULL
DNA-binding	NULL
domain	NULL
,	NULL
p65	NULL
(	NULL
1-312	NULL
)	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
same	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
chicken	NULL
c-re/	NULL
promoter-luciferase	NULL
reporter	NULL
plasmid	NULL
either	NULL
containing	NULL
(	NULL
pLuc-97	NULL
)	NULL
or	NULL
lacking	NULL
(	NULL
pLuc-23	NULL
)	NULL
an	NULL
upstream	NULL
«	NULL
B	NULL
enhancer	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
a	NULL
prior	NULL
report	NULL
(	NULL
50	NULL
)	NULL
,	NULL
Tax	NULL
potently	NULL
activated	NULL
the	NULL
pLuc-97	NULL
reporter	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
inclusion	NULL
of	NULL
the	NULL
RelA	NULL
transdominant	NULL
mutant	NULL
,	NULL
p65	NULL
(	NULL
1-312	NULL
)	NULL
,	NULL
repressed	NULL
these	NULL
stimulatory	NULL
effects	NULL
of	NULL
Tax	NULL
in	NULL
a	NULL
dose-related	NULL
manner	NULL
.	NULL

Tax	NULL
failed	NULL
to	NULL
induce	NULL
the	NULL
pLuc-23	NULL
plasmid	NULL
,	NULL
which	NULL
lacked	NULL
a	NULL
kB	NULL
enhancer	NULL
element	NULL
.	NULL

To	NULL
independently	NULL
test	NULL
whether	NULL
RelA	NULL
regulates	NULL
activation	NULL
of	NULL
the	NULL
c-rel	NULL
gene	NULL
and	NULL
to	NULL
examine	NULL
whether	NULL
the	NULL
c-Rel	NULL
protein	NULL
exerts	NULL
any	NULL
modulatory	NULL
effects	NULL
on	NULL
its	NULL
own	NULL
expression	NULL
,	NULL
cotransfection	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
undifferentiated	NULL
F9	NULL
embryonal	NULL
VoL	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
A	NULL
B	NULL
150	NULL
&	NULL
€	NULL
€	NULL
|	NULL
>	NULL
3	NULL
_	NULL
B	NULL
LIG	NULL
pluc	NULL
-97	NULL
(	NULL
c-re/	NULL
promoter	NULL
xB	NULL
``	NULL
)	NULL
8§	NULL
100	NULL
-	NULL
ZZZ	NULL
plue	NULL
-23	NULL
(	NULL
c-rei	NULL
promoter	NULL
xB	NULL
``	NULL
)	NULL
g	NULL
©	NULL
9	NULL
$	NULL
€3	NULL
°	NULL
c	NULL
s	NULL
0	NULL
=	NULL
3	NULL
3	NULL
%	NULL
so-	NULL
©	NULL
ss	NULL
E	NULL
I	NULL
8	NULL
[	NULL
3	NULL
-	NULL
6	NULL
2	NULL
€	NULL
C	NULL
*~	NULL
235	NULL
0.0	NULL
0.5	NULL
1.0	NULL
2.5	NULL
(	NULL
ug	NULL
)	NULL
[	NULL
peuve	NULL
M	NULL
[	NULL
jpg	NULL
Tax	NULL
]	NULL
ACTIVATION	NULL
OF	NULL
NF-	NULL
«	NULL
B/Rel	NULL
BY	NULL
HTLV-I	NULL
Tax	NULL
PROTEIN	NULL
(	NULL
fold	NULL
induction	NULL
)	NULL
7381	NULL
300	NULL
200-|	NULL
``	NULL
R	NULL
xB	NULL
``	NULL
)	NULL
«	NULL
23	NULL
100-0-	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
c-re/	NULL
promoter	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
and	NULL
RelA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Transactivation	NULL
of	NULL
the	NULL
c-re/	NULL
promoter	NULL
by	NULL
Tax	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
parental	NULL
pCMV4	NULL
vector	NULL
lacking	NULL
a	NULL
cDNA	NULL
insert	NULL
or	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
pCMV4-based	NULL
expression	NULL
vector	NULL
encoding	NULL
Tax	NULL
or	NULL
a	NULL
transdominant	NULL
deletion	NULL
mutant	NULL
of	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
lacking	NULL
the	NULL
C-terminal	NULL
RelA	NULL
activation	NULL
domain	NULL
,	NULL
p65	NULL
(	NULL
1-312	NULL
)	NULL
,	NULL
together	NULL
with	NULL
a	NULL
chicken	NULL
c-re/	NULL
promoter-luciferase	NULL
reporter	NULL
plasmid	NULL
either	NULL
containing	NULL
(	NULL
pLuc-97	NULL
)	NULL
or	NULL
lacking	NULL
(	NULL
pLuc-23	NULL
)	NULL
an	NULL
intrinsic	NULL
kB	NULL
enhancer	NULL
element	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
these	NULL
plasmids	NULL
by	NULL
Tax	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
amounts	NULL
of	NULL
the	NULL
transdominant	NULL
p65	NULL
(	NULL
1-312	NULL
)	NULL
mutant	NULL
was	NULL
determined	NULL
by	NULL
assay	NULL
of	NULL
luciferase	NULL
enzyme	NULL
production	NULL
(	NULL
Promega	NULL
luciferase	NULL
assay	NULL
system	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effects	NULL
of	NULL
c-Rel	NULL
and	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
mutants	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
c-rel	NULL
promoter	NULL
in	NULL
undifferentiated	NULL
F9	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
.	NULL

F9	NULL
cells	NULL
,	NULL
which	NULL
lack	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
,	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
parental	NULL
vector	NULL
pCMV4	NULL
(	NULL
V	NULL
)	NULL
or	NULL
a	NULL
cDNA	NULL
expression	NULL
vector	NULL
encoding	NULL
a	NULL
Tax	NULL
,	NULL
c-Rel	NULL
,	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
,	NULL
or	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
deletion	NULL
mutant	NULL
(	NULL
29	NULL
)	NULL
lacking	NULL
either	NULL
the	NULL
transactivation	NULL
(	NULL
1-312	NULL
)	NULL
or	NULL
DNA-binding	NULL
(	NULL
41-551	NULL
)	NULL
domains	NULL
together	NULL
with	NULL
the	NULL
pLuc-97	NULL
or	NULL
pLuc-23	NULL
reporter	NULL
plasmid	NULL
as	NULL
indicated	NULL
.	NULL

cells	NULL
,	NULL
which	NULL
lack	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Tax	NULL
alone	NULL
failed	NULL
to	NULL
transactivate	NULL
the	NULL
c-re/	NULL
promoter	NULL
in	NULL
these	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
transfection	NULL
of	NULL
a	NULL
RelA	NULL
expression	NULL
plasmid	NULL
produced	NULL
a	NULL
potent	NULL
and	NULL
dose-dependent	NULL
induction	NULL
of	NULL
the	NULL
kB-containing	NULL
c-rel	NULL
promoter	NULL
.	NULL

This	NULL
stimulatory	NULL
action	NULL
of	NULL
RelA	NULL
required	NULL
both	NULL
its	NULL
DNA-binding	NULL
and	NULL
transactivation	NULL
domains	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
the	NULL
p65	NULL
(	NULL
41-551	NULL
)	NULL
and	NULL
p65	NULL
(	NULL
1-312	NULL
)	NULL
RelA	NULL
deletion	NULL
mutants	NULL
,	NULL
which	NULL
lacked	NULL
these	NULL
two	NULL
functional	NULL
domains	NULL
,	NULL
respectively	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
RelA	NULL
,	NULL
transfection	NULL
of	NULL
a	NULL
c-re/	NULL
expression	NULL
vector	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
appreciable	NULL
stimulation	NULL
of	NULL
the	NULL
c-rel	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
when	NULL
coexpressed	NULL
with	NULL
RelA	NULL
,	NULL
c-Rel	NULL
significantly	NULL
repressed	NULL
activation	NULL
of	NULL
the	NULL
c-re/	NULL
promoter	NULL
mediated	NULL
through	NULL
RelA	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
the	NULL
rapidly	NULL
expressed	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
containing	NULL
RelA	NULL
activates	NULL
transcription	NULL
of	NULL
the	NULL
c-re/	NULL
proto-oncogene	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
the	NULL
c-rel	NULL
gene	NULL
is	NULL
subject	NULL
to	NULL
end-product	NULL
inhibition	NULL
by	NULL
the	NULL
subsequent	NULL
accumulation	NULL
of	NULL
nuclear	NULL
c-Rel	NULL
protein	NULL
.	NULL

DISCUSSION	NULL
The	NULL
HTLV-I	NULL
tax	NULL
gene	NULL
product	NULL
is	NULL
a	NULL
potent	NULL
intracellular	NULL
inducer	NULL
of	NULL
nuclear	NULL
NF-kB	NULL
and	NULL
c-Rel	NULL
!	NULL

expression	NULL
(	NULL
3	NULL
,	NULL
74	NULL
)	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
these	NULL
Rel-related	NULL
transcription	NULL
factors	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
genes	NULL
involved	NULL
in	NULL
T-cell	NULL
growth	NULL
.	NULL

The	NULL
deregulated	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
may	NULL
contribute	NULL
to	NULL
T-cell	NULL
transformation	NULL
induced	NULL
by	NULL
HTLV-I	NULL
.	NULL

Indeed	NULL
,	NULL
antisense	NULL
oligo-nucleotides	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
have	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
the	NULL
growth	NULL
of	NULL
HTLV-I	NULL
Tax-induced	NULL
-tumor	NULL
cells	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Despite	NULL
this	NULL
apparent	NULL
important	NULL
functional	NULL
interplay	NULL
between	NULL
Tax	NULL
and	NULL
NF-	NULL
«	NULL
B/Rel	NULL
,	NULL
the	NULL
underlying	NULL
mechanism	NULL
by	NULL
which	NULL
this	NULL
viral	NULL
transactivator	NULL
induces	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
these	NULL
host	NULL
transcription	NULL
factors	NULL
has	NULL
remained	NULL
elusive	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
Tax	NULL
physically	NULL
associates	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
and	NULL
NF-	NULL
«	NULL
kB2	NULL
gene	NULL
products	NULL
,	NULL
p105	NULL
and	NULL
p100	NULL
(	NULL
16	NULL
,	NULL
40	NULL
)	NULL
,	NULL
which	NULL
are	NULL
precursors	NULL
of	NULL
p50	NULL
and	NULL
p52	NULL
,	NULL
respectively	NULL
(	NULL
17	NULL
,	NULL
18	NULL
,	NULL
32	NULL
,	NULL
47	NULL
,	NULL
53	NULL
,	NULL
58	NULL
,	NULL
68	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
transient	NULL
transfection	NULL
model	NULL
,	NULL
Watanabe	NULL
et	NULL
al	NULL
.	NULL

have	NULL
reported	NULL
that	NULL
the	NULL
physical	NULL
interaction	NULL
of	NULL
Tax	NULL
may	NULL
override	NULL
the	NULL
cytoplasmic	NULL
sequestration	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
by	NULL
p105	NULL
which	NULL
functions	NULL
like	NULL
an	NULL
IxB	NULL
molecule	NULL
(	NULL
86	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
Hirai	NULL
and	NULL
colleagues	NULL
have	NULL
recently	NULL
demonstrated	NULL
a	NULL
physical	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
the	NULL
ankyrin	NULL
repeats	NULL
present	NULL
in	NULL
the	NULL
C-terminal	NULL
portion	NULL
of	NULL
p105	NULL
(	NULL
41	NULL
)	NULL
,	NULL
a	NULL
region	NULL
proposed	NULL
to	NULL
encode	NULL
IxBy	NULL
(	NULL
45	NULL
)	NULL
.	NULL

The	NULL
authors	NULL
propose	NULL
that	NULL
this	NULL
interaction	NULL
may	NULL
promote	NULL
nuclear	NULL
translocation	NULL
of	NULL
RelA	NULL
.	NULL

Unfortunately	NULL
,	NULL
the	NULL
relevance	NULL
of	NULL
these	NULL
findings	NULL
is	NULL
uncertain	NULL
since	NULL
IxBy	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
identified	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
these	NULL
results	NULL
with	NULL
p105	NULL
,	NULL
our	NULL
recent	NULL
studies	NULL
of	NULL
the	NULL
physical	NULL
interplay	NULL
of	NULL
Tax	NULL
and	NULL
p100	NULL
have	NULL
revealed	NULL
a	NULL
very	NULL
different	NULL
functional	NULL
consequence	NULL
.	NULL

Specifically	NULL
,	NULL
the	NULL
association	NULL
of	NULL
Tax	NULL
with	NULL
p100	NULL
leads	NULL
to	NULL
the	NULL
cytoplasmic	NULL
sequestration	NULL
of	NULL
this	NULL
transactivator	NULL
and	NULL
marked	NULL
inhibition	NULL
of	NULL
its	NULL
inductive	NULL
effects	NULL
on	NULL
both	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
«	NULL
kB	NULL
enhancer	NULL
(	NULL
16	NULL
)	NULL
.	NULL

As	NULL
such	NULL
,	NULL
these	NULL
inhibitory	NULL
effects	NULL
of	NULL
p100	NULL
on	NULL
Tax	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
profound	NULL
state	NULL
of	NULL
viral	NULL
latency	NULL
that	NULL
characterizes	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
83	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
have	NULL
assembled	NULL
no	NULL
evidence	NULL
indicating	NULL
that	NULL
Tax	NULL
association	NULL
with	NULL
p100	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
or	NULL
related	NULL
complexes	NULL
.	NULL

Specifically	NULL
,	NULL
in	NULL
our	NULL
hands	NULL
,	NULL
Tax	NULL
fails	NULL
to	NULL
induce	NULL
the	NULL
processing	NULL
of	NULL
p100	NULL
to	NULL
p52	NULL
and	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
the	NULL
physical	NULL
dissociation	NULL
of	NULL
p100	NULL
from	NULL
RelA	NULL
(	NULL
14a	NULL
)	NULL
.	NULL

As	NULL
such	NULL
,	NULL
the	NULL
mechanism	NULL
of	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
c-Rel	NULL
remains	NULL
elusive	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
possibility	NULL
that	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
c-Rel	NULL
is	NULL
mediated	NULL
through	NULL
the	NULL
induced	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
the	NULL
major	NULL
cytoplasmic	NULL
inhibitor	NULL
of	NULL
the	NULL
RelA	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

We	NULL
have	NULL
in	NULL
fact	NULL
found	NULL
that	NULL
a	NULL
large	NULL
portion	NULL
of	NULL
IxBa	NULL
is	NULL
phosphorylated	NULL
in	NULL
all	NULL
three	NULL
of	NULL
the	NULL
HTLV	NULL
T-cell	NULL
lines	NULL
investigated	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
I	NULL
«	NULL
xBa	NULL
in	NULL
these	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
result	NULL
of	NULL
Tax	NULL
action	NULL
since	NULL
Tax	NULL
is	NULL
the	NULL
only	NULL
viral	NULL
gene	NULL
product	NULL
expressed	NULL
in	NULL
C8166	NULL
cells	NULL
(	NULL
67	NULL
)	NULL
,	NULL
and	NULL
similar	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
is	NULL
observed	NULL
in	NULL
Jurkat	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
sense	NULL
but	NULL
not	NULL
antisense	NULL
Tax	NULL
cDNA	NULL
expression	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
degree	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
appears	NULL
correlated	NULL
with	NULL
the	NULL
intracellular	NULL
level	NULL
of	NULL
Tax	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

7382	NULL
SUN	NULL
ET	NULL
AL	NULL
.	NULL

Prior	NULL
in	NULL
vitro	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
with	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
or	NULL
PKA	NULL
leads	NULL
to	NULL
its	NULL
rapid	NULL
physical	NULL
release	NULL
from	NULL
the	NULL
NF-kB	NULL
complex	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
our	NULL
in	NULL
vivo	NULL
data	NULL
have	NULL
revealed	NULL
that	NULL
at	NULL
least	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
remains	NULL
physically	NULL
associated	NULL
with	NULL
RelA	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
its	NULL
coimmunoprecipitation	NULL
with	NULL
RelA	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

These	NULL
in	NULL
vivo	NULL
findings	NULL
suggest	NULL
that	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
alone	NULL
may	NULL
not	NULL
be	NULL
sufficient	NULL
to	NULL
activate	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
NF-kB	NULL
complex	NULL
.	NULL

Indeed	NULL
,	NULL
consistent	NULL
with	NULL
several	NULL
prior	NULL
studies	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
mitogens	NULL
and	NULL
cytokines	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
(	NULL
13	NULL
,	NULL
19	NULL
,	NULL
38	NULL
,	NULL
79	NULL
)	NULL
,	NULL
our	NULL
current	NULL
data	NULL
suggest	NULL
that	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
triggers	NULL
proteolytic	NULL
degradation	NULL
of	NULL
this	NULL
inhibitor	NULL
.	NULL

Specifically	NULL
,	NULL
phosphorylated	NULL
IxBa	NULL
present	NULL
in	NULL
the	NULL
Tax-expressing	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
exhibits	NULL
a	NULL
remarkably	NULL
shorter	NULL
intracellular	NULL
survival	NULL
(	NULL
¢	NULL
;	NULL
,	NULL
,	NULL
<	NULL
5	NULL
min	NULL
)	NULL
than	NULL
the	NULL
unmodified	NULL
IxBa	NULL
present	NULL
in	NULL
the	NULL
noninfected	NULL
non-Tax-expressing	NULL
Jurkat	NULL
cells	NULL
(	NULL
;	NULL
,	NULL
,	NULL
>	NULL
2	NULL
h	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

While	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
Tax	NULL
induces	NULL
both	NULL
specific	NULL
kinases	NULL
and	NULL
pro-teases	NULL
,	NULL
which	NULL
act	NULL
independently	NULL
to	NULL
eliminate	NULL
IxBa	NULL
,	NULL
we	NULL
suspect	NULL
that	NULL
these	NULL
are	NULL
contingent	NULL
events	NULL
and	NULL
that	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
serves	NULL
as	NULL
a	NULL
molecular	NULL
trigger	NULL
for	NULL
IxBa	NULL
degradation	NULL
by	NULL
one	NULL
or	NULL
more	NULL
cellular	NULL
proteases	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
our	NULL
prior	NULL
pulse-chase	NULL
experiments	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
transiently	NULL
expressed	NULL
free	NULL
molecules	NULL
are	NULL
rapidly	NULL
degraded	NULL
(	NULL
;	NULL
,	NULL
,	NULL
=	NULL
40	NULL
min	NULL
)	NULL
even	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
albeit	NULL
with	NULL
slower	NULL
kinetics	NULL
than	NULL
phosphorylated	NULL
IxBa	NULL
(	NULL
¢	NULL
;	NULL
,	NULL
,	NULL
<	NULL
5	NULL
min	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
coexpressed	NULL
with	NULL
RelA	NULL
,	NULL
the	NULL
intracellular	NULL
survival	NULL
of	NULL
IxBa	NULL
is	NULL
markedly	NULL
prolonged	NULL
(	NULL
79	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
the	NULL
sites	NULL
involved	NULL
in	NULL
protease	NULL
attack	NULL
within	NULL
IxBa	NULL
are	NULL
masked	NULL
when	NULL
this	NULL
inhibitor	NULL
is	NULL
complexed	NULL
with	NULL
RelA	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
phosphorylation	NULL
may	NULL
lead	NULL
to	NULL
the	NULL
conformational	NULL
changes	NULL
in	NULL
the	NULL
IxBa	NULL
molecule	NULL
that	NULL
allows	NULL
protease	NULL
attack	NULL
to	NULL
begin	NULL
even	NULL
while	NULL
the	NULL
inhibitor	NULL
is	NULL
physically	NULL
complexed	NULL
with	NULL
RelA	NULL
.	NULL

It	NULL
also	NULL
seems	NULL
likely	NULL
that	NULL
constitutive	NULL
and	NULL
inducible	NULL
pathways	NULL
of	NULL
IxBa	NULL
degradation	NULL
exist	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
identify	NULL
inhibitors	NULL
of	NULL
the	NULL
cellular	NULL
protease	NULL
mediating	NULL
IxBa	NULL
degradation	NULL
,	NULL
we	NULL
tested	NULL
a	NULL
number	NULL
of	NULL
different	NULL
protease	NULL
inhibitors	NULL
,	NULL
including	NULL
TPCK	NULL
,	NULL
an	NULL
agent	NULL
which	NULL
blocks	NULL
chymotrypsin-like	NULL
enzymes	NULL
.	NULL

However	NULL
,	NULL
while	NULL
TPCK	NULL
effectively	NULL
blocked	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
c-Rel	NULL
,	NULL
this	NULL
agent	NULL
also	NULL
blocked	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
occurring	NULL
in	NULL
response	NULL
to	NULL
either	NULL
Tax	NULL
or	NULL
TNF-	NULL
«	NULL
.	NULL

Thus	NULL
,	NULL
TPCK	NULL
appeared	NULL
to	NULL
act	NULL
at	NULL
a	NULL
point	NULL
prior	NULL
to	NULL
phosphorylation	NULL
of	NULL
the	NULL
inhibitor	NULL
rather	NULL
than	NULL
distally	NULL
to	NULL
block	NULL
the	NULL
protease	NULL
(	NULL
s	NULL
)	NULL
that	NULL
degrades	NULL
IxBa	NULL
.	NULL

Similar	NULL
inhibitory	NULL
effects	NULL
on	NULL
IxBa	NULL
phosphorylation	NULL
were	NULL
obtained	NULL
with	NULL
pyrro-lidinedithiocarbamate	NULL
,	NULL
a	NULL
chelator	NULL
and	NULL
scavenger	NULL
of	NULL
free	NULL
radicals	NULL
known	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
many	NULL
stimuli	NULL
,	NULL
including	NULL
Tax	NULL
and	NULL
TNF-	NULL
«	NULL
.	NULL

This	NULL
possibility	NULL
is	NULL
reminiscent	NULL
of	NULL
recent	NULL
studies	NULL
with	NULL
the	NULL
hepatitis	NULL
B	NULL
virus	NULL
x	NULL
protein	NULL
,	NULL
which	NULL
have	NULL
revealed	NULL
that	NULL
this	NULL
transactivator	NULL
mimics	NULL
tumor	NULL
promoters	NULL
and	NULL
acts	NULL
by	NULL
stimulating	NULL
a	NULL
PKC-dependent	NULL
signaling	NULL
pathway	NULL
(	NULL
46	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Tax	NULL
activation	NULL
of	NULL
NF-xB/Rel	NULL
appears	NULL
to	NULL
involve	NULL
a	NULL
PKC-independent	NULL
pathway	NULL
since	NULL
Tax-mediated	NULL
IxBa	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
are	NULL
not	NULL
inhibited	NULL
by	NULL
various	NULL
PKC	NULL
inhibitors	NULL
,	NULL
including	NULL
staurosporin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Studies	NULL
are	NULL
now	NULL
under	NULL
way	NULL
to	NULL
define	NULL
the	NULL
intracellular	NULL
signaling	NULL
pathway	NULL
involved	NULL
in	NULL
Tax	NULL
action	NULL
.	NULL

In	NULL
Tax-expressing	NULL
cells	NULL
,	NULL
both	NULL
RelA	NULL
and	NULL
c-Rel	NULL
are	NULL
constitutively	NULL
expressed	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
reference	NULL
3	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

While	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
RelA	NULL
is	NULL
likely	NULL
the	NULL
direct	NULL
result	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
,	NULL
Tax	NULL
induction	NULL
of	NULL
nuclear	NULL
c-Rel	NULL
expression	NULL
appears	NULL
to	NULL
involve	NULL
a	NULL
more	NULL
complex	NULL
mechanism	NULL
.	NULL

As	NULL
noted	NULL
previously	NULL
,	NULL
our	NULL
prior	NULL
studies	NULL
have	NULL
demonstrated	NULL
distinctly	NULL
different	NULL
kinetics	NULL
of	NULL
NF-kB	NULL
and	NULL
c-Rel	NULL
expression	NULL
following	NULL
PMA	NULL
or	NULL
TNF-	NULL
«	NULL
stimulation	NULL
(	NULL
26	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Nuclear	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
occurs	NULL
within	NULL
minutes	NULL
,	NULL
while	NULL
nuclear	NULL
c-Rel	NULL
expression	NULL
is	NULL
delayed	NULL
for	NULL
several	NULL
hours	NULL
after	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

stimulation	NULL
and	NULL
importantly	NULL
requires	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
.	NULL

Our	NULL
current	NULL
studies	NULL
now	NULL
demonstrate	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activates	NULL
c-rel	NULL
gene	NULL
expression	NULL
via	NULL
a	NULL
xB	NULL
enhancer	NULL
element	NULL
located	NULL
in	NULL
the	NULL
promoter-proximal	NULL
region	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
subsequent	NULL
accumulation	NULL
of	NULL
nuclear	NULL
c-Rel	NULL
protein	NULL
serves	NULL
to	NULL
inhibit	NULL
RelA-mediated	NULL
activation	NULL
of	NULL
the	NULL
c-re/	NULL
gene	NULL
.	NULL

These	NULL
findings	NULL
reveal	NULL
an	NULL
intriguing	NULL
and	NULL
unexpected	NULL
regulatory	NULL
network	NULL
whereby	NULL
different	NULL
Rel	NULL
proteins	NULL
control	NULL
not	NULL
only	NULL
their	NULL
own	NULL
expression	NULL
but	NULL
also	NULL
that	NULL
of	NULL
other	NULL
Rel	NULL
family	NULL
members	NULL
and	NULL
their	NULL
cytoplasmic	NULL
inhibitors	NULL
(	NULL
9	NULL
,	NULL
25	NULL
,	NULL
71	NULL
,	NULL
79	NULL
)	NULL
.	NULL

Tax	NULL
expression	NULL
in	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
may	NULL
serve	NULL
to	NULL
override	NULL
this	NULL
autoregulatory	NULL
cycle	NULL
,	NULL
leading	NULL
to	NULL
sustained	NULL
high-level	NULL
nuclear	NULL
expression	NULL
of	NULL
both	NULL
RelA	NULL
and	NULL
c-Rel	NULL
.	NULL

As	NULL
such	NULL
,	NULL
this	NULL
abnormal	NULL
pattern	NULL
of	NULL
nuclear	NULL
expression	NULL
of	NULL
these	NULL
Rel-related	NULL
proteins	NULL
may	NULL
contribute	NULL
to	NULL
HTLV-I-medi-ated	NULL
T-cell	NULL
transformation	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
acknowledge	NULL
the	NULL
late	NULL
H.	NULL
M.	NULL
Temin	NULL
for	NULL
providing	NULL
the	NULL
pLuc-23	NULL
and	NULL
pLuc-97	NULL
plasmids	NULL
and	NULL
C.	NULL
Rosen	NULL
for	NULL
the	NULL
human	NULL
RelA	NULL
cDNA	NULL
.	NULL

S	NULL
$	NULL
.-C.S	NULL
.	NULL

is	NULL
a	NULL
scholar	NULL
of	NULL
American	NULL
Foundation	NULL
for	NULL
AIDS	NULL
Research	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Alexandre	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
B.	NULL
Verrier	NULL
.	NULL

1991	NULL
.	NULL

Four	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
c-fos	NULL
promoter	NULL
mediate	NULL
transactivation	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
protein	NULL
.	NULL

Oncogene	NULL
6:543-551	NULL
.	NULL

2	NULL
.	NULL

Andersson	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Davis	NULL
,	NULL
H.	NULL
Dahlback	NULL
,	NULL
H.	NULL
Jornvall	NULL
,	NULL
and	NULL
K.	NULL
W.	NULL
Russell	NULL
.	NULL

1989	NULL
.	NULL

Cloning	NULL
,	NULL
structure	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
mitochon-drial	NULL
cytochrome	NULL
P-450	NULL
sterol	NULL
26-hydroxylase	NULL
,	NULL
a	NULL
bile	NULL
acid	NULL
biosyn-thetic	NULL
enzyme	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:8222-8229	NULL
.	NULL

3	NULL
.	NULL

Arima	NULL
,	NULL
N.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Molitor	NULL
,	NULL
M.	NULL
R.	NULL
Smith	NULL
,	NULL
J.	NULL
H.	NULL
Kim	NULL
,	NULL
Y.	NULL
Daitoku	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
induces	NULL
expression	NULL
of	NULL
the	NULL
Rel-related	NULL
family	NULL
of	NULL
kB	NULL
enhancer-binding	NULL
proteins	NULL
:	NULL
evidence	NULL
for	NULL
a	NULL
pretranslational	NULL
component	NULL
of	NULL
regulation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:6892-6899	NULL
.	NULL

4	NULL
.	NULL

Auberger	NULL
,	NULL
P.	NULL
,	NULL
D.	NULL
Mary	NULL
,	NULL
J.-P.	NULL
Breittmayer	NULL
,	NULL
C.	NULL
Aussel	NULL
,	NULL
and	NULL
M.	NULL
Fehlmann	NULL
.	NULL

1989	NULL
.	NULL

Chymotryptic-type	NULL
protease	NULL
inhibitors	NULL
block	NULL
the	NULL
increase	NULL
in	NULL
Ca**	NULL
and	NULL
IL-2	NULL
production	NULL
in	NULL
activated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:1253-1259	NULL
.	NULL

5	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072:63-80	NULL
.	NULL

6	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217	NULL
.	NULL

7	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546	NULL
.	NULL

8	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-B	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698	NULL
.	NULL

9	NULL
.	NULL

Bail	NULL
,	NULL
O.	NULL
L.	NULL
,	NULL
R.	NULL
Schmidt-Ullrich	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1993	NULL
.	NULL

Promoter	NULL
analysis	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
IxB-	NULL
«	NULL
/MAD3	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
positive	NULL
regulation	NULL
by	NULL
members	NULL
of	NULL
the	NULL
rel/NF-	NULL
«	NULL
B	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:5043-5049	NULL
.	NULL

10	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
Hoffman	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
gene	NULL
:	NULL
regulatory	NULL
role	NULL
for	NULL
DNA-protein	NULL
interactions	NULL
flanking	NULL
the	NULL
xB	NULL
enhancer	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

1:83-92	NULL
.	NULL

11	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
induces	NULL
cellular	NULL
proteins	NULL
that	NULL
activate	NULL
the	NULL
xB	NULL
element	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
«	NULL
gene	NULL
.	NULL

Science	NULL
241:1652-1654	NULL
.	NULL

12	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
65-kDa	NULL
subunit	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
and	NULL
a	NULL
target	NULL
for	NULL
v-Rel-mediated	NULL
repression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
:	NULL
1875-1879	NULL
.	NULL

13	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
IxBa	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301-3310	NULL
.	NULL

VoL	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
14	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
R.	NULL
I.	NULL
Scheinman	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1992	NULL
.	NULL

IxB	NULL
interacts	NULL
with	NULL
the	NULL
nuclear	NULL
localization	NULL
sequence	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-kB	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
cytoplasmic	NULL
retention	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1899-1913	NULL
.	NULL

14a.Béraud	NULL
,	NULL
C.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

Béraud	NULL
,	NULL
C.	NULL
,	NULL
G.	NULL
Lombard-Platet	NULL
,	NULL
Y.	NULL
Michal	NULL
,	NULL
and	NULL
P.	NULL
Jalinot	NULL
.	NULL

1991	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
HTLV-1	NULL
Tax1	NULL
transactivator	NULL
to	NULL
the	NULL
inducible	NULL
21	NULL
bp	NULL
enhancer	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
cellular	NULL
factor	NULL
HEB1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3795-3803	NULL
.	NULL

Béraud	NULL
,	NULL
C.	NULL
,	NULL
S.-C.	NULL
Sun	NULL
,	NULL
P.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
associates	NULL
with	NULL
and	NULL
is	NULL
negatively	NULL
regulated	NULL
by	NULL
the	NULL
NF-	NULL
«	NULL
B2	NULL
p100	NULL
gene	NULL
product	NULL
:	NULL
implications	NULL
for	NULL
viral	NULL
latency	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1374-1382	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
mitogen-inducible	NULL
gene	NULL
encoding	NULL
a	NULL
kB	NULL
DNA-binding	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
and	NULL
to	NULL
cell-cycle	NULL
motifs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:76-80	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
R.-P.	NULL
Ryseck	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
1992	NULL
.	NULL

A	NULL
novel	NULL
mitogen-inducible	NULL
gene	NULL
product	NULL
related	NULL
to	NULL
p50/p105-NF-	NULL
«	NULL
B	NULL
participates	NULL
in	NULL
transactivation	NULL
through	NULL
a	NULL
«	NULL
B	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:685-695	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Granzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-kB	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IxB-	NULL
«	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2532-2536	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
N.	NULL
Mittereder	NULL
,	NULL
and	NULL
N.	NULL
Rice	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
human	NULL
rel	NULL
proto-oncogene	NULL
cDNA	NULL
containing	NULL
an	NULL
Alu	NULL
fragment	NULL
as	NULL
a	NULL
potential	NULL
coding	NULL
exon	NULL
.	NULL

Oncogene	NULL
4:935-942	NULL
.	NULL

Chen	NULL
,	NULL
I.	NULL
S.	NULL
Y.	NULL
,	NULL
D.	NULL
J.	NULL
Slamon	NULL
,	NULL
J.	NULL
D.	NULL
Rosenblatt	NULL
,	NULL
N.	NULL
P.	NULL
Shah	NULL
,	NULL
S.	NULL
G.	NULL
Quan	NULL
,	NULL
and	NULL
W.	NULL
Wachsman	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
x	NULL
gene	NULL
is	NULL
essential	NULL
for	NULL
HTLV	NULL
replication	NULL
.	NULL

Science	NULL
229:54-58	NULL
.	NULL

Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
R.	NULL
Donald	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Read	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
,	NULL
1993	NULL
.	NULL

Lipopolysaccharide	NULL
induces	NULL
phosphorylation	NULL
of	NULL
MAD3	NULL
and	NULL
activation	NULL
of	NULL
c-Rel	NULL
and	NULL
related	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
in	NULL
human	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:11803-11810	NULL
.	NULL

Crenon	NULL
,	NULL
I.	NULL
,	NULL
C.	NULL
Beraud	NULL
,	NULL
P.	NULL
Simard	NULL
,	NULL
J.	NULL
Montafne	NULL
,	NULL
P.	NULL
Veschambre	NULL
,	NULL
and	NULL
P.	NULL
Jalinot	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
transcriptionally	NULL
active	NULL
factors	NULL
mediating	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
HTLV-1	NULL
Tax	NULL
transactivator	NULL
on	NULL
the	NULL
IL-2Ra	NULL
«	NULL
B	NULL
enhancer	NULL
include	NULL
the	NULL
product	NULL
of	NULL
the	NULL
c-rel	NULL
proto-oncogene	NULL
.	NULL

Oncogene	NULL
8:867-875	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Wolf	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
chain	NULL
promoter	NULL
:	NULL
activation	NULL
of	NULL
a	NULL
nonfunctional	NULL
promoter	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
of	NULL
HTLV-1	NULL
.	NULL

Cell	NULL
49:47-56.	NULL
de	NULL
Martin	NULL
,	NULL
R.	NULL
,	NULL
B.	NULL
Vanhove	NULL
,	NULL
Q.	NULL
Cheng	NULL
,	NULL
E.	NULL
Hofer	NULL
,	NULL
V.	NULL
Csizmadia	NULL
,	NULL
H.	NULL
Winkler	NULL
,	NULL
and	NULL
F.	NULL
H.	NULL
Bach	NULL
.	NULL

1993	NULL
.	NULL

Cytokine-inducible	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
of	NULL
an	NULL
IxBa-like	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
NFkB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:2773	NULL
.	NULL

Doerre	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Sista	NULL
,	NULL
S.-C.	NULL
Sun	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
c-rel	NULL
protooncogene	NULL
product	NULL
represses	NULL
NF-kB	NULL
p65-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:1023-1027	NULL
.	NULL

Feuer	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1992	NULL
.	NULL

Mechanisms	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus-induced	NULL
leukemogenesis	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1114:223-233	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Sassone-Corsi	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1988.	NULL
c-fos	NULL
promoter	NULL
transactivation	NULL
by	NULL
the	NULL
tax	NULL
,	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:8526-8530	NULL
.	NULL

Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
S.-C.	NULL
Sun	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1992	NULL
.	NULL

I	NULL
«	NULL
xB/MAD-3	NULL
masks	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
NF-kB	NULL
p65	NULL
and	NULL
acts	NULL
with	NULL
the	NULL
C-terminal	NULL
activation	NULL
domain	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
3	NULL
;	NULL
:1339-1352	NULL
.	NULL

Gessain	NULL
,	NULL
A.	NULL
,	NULL
F.	NULL
Barin	NULL
,	NULL
J.	NULL
C.	NULL
Vernant	NULL
,	NULL
O.	NULL
Gout	NULL
,	NULL
L.	NULL
Maurs	NULL
,	NULL
A.	NULL
Calender	NULL
,	NULL
and	NULL
G.	NULL
de	NULL
The	NULL
.	NULL

1985	NULL
.	NULL

Antibodies	NULL
to	NULL
the	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type-1	NULL
in	NULL
patients	NULL
with	NULL
tropical	NULL
spastic	NULL
parapa-resis	NULL
.	NULL

Lancet	NULL
ii:407-410	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IxB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:678-682	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
L.	NULL
R.	NULL
Riviere	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-kB	NULL
:	NULL
homology	NULL
to	NULL
re/	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019-1029	NULL
.	NULL

ACTIVATION	NULL
OF	NULL
NF-	NULL
«	NULL
B/Rel	NULL
BY	NULL
HTLV-I	NULL
Tax	NULL
PROTEIN	NULL
33	NULL
34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

7383	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
1990	NULL
.	NULL

NF-kB	NULL
,	NULL
KBF1	NULL
,	NULL
dorsal	NULL
,	NULL
and	NULL
related	NULL
matters	NULL
.	NULL

Cell	NULL
62:841-843	NULL
.	NULL

Green	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
expression	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

4:169-175	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1989	NULL
.	NULL

HIV-1	NULL
,	NULL
HTLV-1	NULL
and	NULL
normal	NULL
T-cell	NULL
growth	NULL
:	NULL
transcriptional	NULL
strategies	NULL
and	NULL
surprises	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
10:272-278	NULL
.	NULL

Hannink	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
H.	NULL
M.	NULL
Temin	NULL
.	NULL

1990	NULL
.	NULL

Structure	NULL
and	NULL
autoregulation	NULL
of	NULL
the	NULL
c-rel	NULL
promoter	NULL
.	NULL

Oncogene	NULL
5:1843-1850	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
I.	NULL
Alkalay	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
Y.	NULL
Ben-Nerlah	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
I	NULL
«	NULL
B-	NULL
«	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
365:182-185	NULL
.	NULL

Hinrichs	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
M.	NULL
Nerenberg	NULL
,	NULL
K.	NULL
Reynolds	NULL
,	NULL
G.	NULL
Khoury	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
transgenic	NULL
mouse	NULL
model	NULL
for	NULL
human	NULL
neurofibromato-sis	NULL
.	NULL

Science	NULL
237:1340-1343	NULL
.	NULL

Hirai	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
K.	NULL
Ueda	NULL
,	NULL
M.	NULL
Muramatsu	NULL
,	NULL
A.	NULL
Tsuboi	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
activator	NULL
Tax	NULL
of	NULL
HTLV-I	NULL
binds	NULL
to	NULL
the	NULL
NF-kB	NULL
precursor	NULL
p105	NULL
.	NULL

Oncogene	NULL
7:1737-1742	NULL
.	NULL

Hirai	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.-I	NULL
.	NULL

Fujisawa	NULL
,	NULL
J.-I	NULL
.	NULL

Inoue	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1994	NULL
.	NULL

Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
binds	NULL
to	NULL
the	NULL
ankyrin	NULL
motifs	NULL
of	NULL
inhibitory	NULL
factor	NULL
«	NULL
B	NULL
and	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:3584-3588	NULL
.	NULL

Holbrook	NULL
,	NULL
N.	NULL
,	NULL
A.	NULL
Gulino	NULL
,	NULL
and	NULL
F.	NULL
Ruscetti	NULL
.	NULL

1987	NULL
.	NULL

Cis-acting	NULL
transcriptional	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
gibbon	NULL
ape	NULL
leukemia	NULL
virus	NULL
(	NULL
GALV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Virology	NULL
157:211-219	NULL
.	NULL

Hoyos	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
M.	NULL
Siekevitz	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Kappa	NULL
B-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
:	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
human	NULL
interleukin-2	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
244	NULL
:	NULL
457-460.	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
S.	NULL
Tsuru	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1986	NULL
.	NULL

Induction	NULL
of	NULL
interleukin-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
p4O0x	NULL
encoded	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
EMBO	NULL
J	NULL
.	NULL

5:2883-2888	NULL
.	NULL

Inoue	NULL
,	NULL
J.-L.	NULL
,	NULL
L.	NULL
D.	NULL
Kerr	NULL
,	NULL
A.	NULL
Kakizuka	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1992	NULL
.	NULL

IkBy	NULL
,	NULL
a	NULL
70	NULL
kd	NULL
protein	NULL
identical	NULL
to	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
p110	NULL
NF-kB	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
.	NULL

Cell	NULL
68:1109-1120	NULL
.	NULL

Kekulé	NULL
,	NULL
A.	NULL
,	NULL
U.	NULL
Lauer	NULL
,	NULL
L.	NULL
Weiss	NULL
,	NULL
B.	NULL
Luber	NULL
,	NULL
and	NULL
P.	NULL
H.	NULL
Hofschneider	NULL
.	NULL

1993	NULL
.	NULL

Hepatitis	NULL
B	NULL
virus	NULL
transactivator	NULL
HBx	NULL
uses	NULL
a	NULL
tumour	NULL
promoter	NULL
signalling	NULL
pathway	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
361:742-745	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerie	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF-1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Kitajima	NULL
,	NULL
L.	NULL
,	NULL
T.	NULL
Shinohara	NULL
,	NULL
J.	NULL
Bilakovics	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

Brown	NULL
,	NULL
X.	NULL
Xu	NULL
,	NULL
and	NULL
M.	NULL
Nerenberg	NULL
.	NULL

1992	NULL
.	NULL

Ablation	NULL
of	NULL
transplanted	NULL
HTLV-I	NULL
Tax-transformed	NULL
tumors	NULL
in	NULL
mice	NULL
by	NULL
antisense	NULL
inhibition	NULL
of	NULL
NF-KB	NULL
.	NULL

Science	NULL
258:1792-1795	NULL
.	NULL

Lanoix	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
Lacoste	NULL
,	NULL
N.	NULL
Pepin	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1994	NULL
.	NULL

Overproduction	NULL
of	NULL
NFB2	NULL
(	NULL
lyt-10	NULL
)	NULL
and	NULL
c-Rel	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
HTLV-I	NULL
Tax-mediated	NULL
trans-activation	NULL
via	NULL
the	NULL
NF-kappa	NULL
B	NULL
signalling	NULL
pathway	NULL
.	NULL

Oncogene	NULL
9:841-852	NULL
.	NULL

Li	NULL
,	NULL
C.-C.	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
E.	NULL
Chen	NULL
,	NULL
N.-S.	NULL
Yang	NULL
,	NULL
J.	NULL
Mikovits	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Longo	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
Rel	NULL
family	NULL
members	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
l-infected	NULL
cells	NULL
:	NULL
transcriptional	NULL
activation	NULL
of	NULL
c-rel	NULL
by	NULL
Tax	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:4205-4213	NULL
.	NULL

Maruyama	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
M.	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
J.	NULL
I.	NULL
Inoue	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1987	NULL
.	NULL

Evidence	NULL
for	NULL
aberrant	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
autocrine	NULL
loop	NULL
by	NULL
HTLV-1-encoded	NULL
p40x	NULL
and	NULL
T3/Ti	NULL
complex	NULL
triggering	NULL
.	NULL

Cell	NULL
48:343-350	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
DiDonato	NULL
,	NULL
C.	NULL
Rosette	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1993.	NULL
p105	NULL
and	NULL
p98	NULL
precursor	NULL
proteins	NULL
play	NULL
an	NULL
active	NULL
role	NULL
in	NULL
NF-kB-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:705-718	NULL
.	NULL

7384	NULL
53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

SUN	NULL
ET	NULL
AL	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
N.	NULL
Hatada	NULL
,	NULL
H.-P.	NULL
Hohmann	NULL
,	NULL
M.	NULL
Haiker	NULL
,	NULL
C.	NULL
Bartsch	NULL
,	NULL
U.	NULL
Rothlisberger	NULL
,	NULL
H.-W.	NULL
Lahm	NULL
,	NULL
E.	NULL
J.	NULL
Schlaeger	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
van	NULL
Loon	NULL
,	NULL
and	NULL
C.	NULL
Schreidereit	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
human	NULL
nuclear	NULL
factor	NULL
xB	NULL
:	NULL
the	NULL
level	NULL
of	NULL
its	NULL
mRNA	NULL
is	NULL
strongly	NULL
regulated	NULL
by	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:966-970	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
H.	NULL
Walker	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differentially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:10028-10032	NULL
.	NULL

Nagata	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Ohtani	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
endogenous	NULL
c-fos	NULL
proto-oncogene	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I-encoded	NULL
p40**	NULL
protein	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
line	NULL
,	NULL
Jurkat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:3220-3226	NULL
.	NULL

Naumann	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
G.	NULL
Wulezyn	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
,	NULL
1993	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
precursor	NULL
p105	NULL
and	NULL
the	NULL
proto-oncogene	NULL
product	NULL
Bel-3	NULL
are	NULL
IxB	NULL
molecules	NULL
and	NULL
control	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:213-222	NULL
.	NULL

Nerenberg	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
H.	NULL
Hinrichs	NULL
,	NULL
R.	NULL
K.	NULL
Reynolds	NULL
,	NULL
G.	NULL
Khoury	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
tat	NULL
gene	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
induces	NULL
mesenchymal	NULL
tumors	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Science	NULL
237	NULL
:	NULL
1324-1329	NULL
.	NULL

Neri	NULL
,	NULL
A.	NULL
,	NULL
C.-C.	NULL
Chang	NULL
,	NULL
L.	NULL
Lombardi	NULL
,	NULL
M.	NULL
Salina	NULL
,	NULL
P.	NULL
Corradini	NULL
,	NULL
A.	NULL
T.	NULL
Maiolo	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
Chaganti	NULL
,	NULL
and	NULL
R.	NULL
Dalla-Favera	NULL
.	NULL

1991	NULL
.	NULL

B	NULL
cell	NULL
lymphoma-associated	NULL
chromosomal	NULL
translocation	NULL
involves	NULL
candidate	NULL
oncogene	NULL
Byt-10	NULL
,	NULL
homologous	NULL
to	NULL
NF-kB	NULL
p50	NULL
.	NULL

Cell	NULL
67:1075-1087	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
D.	NULL
Baitimore	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
IxB	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-KB	NULL
,	NULL
a	NULL
rel-related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961-968	NULL
.	NULL

Osame	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Usuku	NULL
,	NULL
N.	NULL
Ijichi	NULL
,	NULL
H.	NULL
Amitani	NULL
,	NULL
A.	NULL
Igata	NULL
,	NULL
M.	NULL
Mat-sumoto	NULL
,	NULL
and	NULL
H.	NULL
Tara	NULL
.	NULL

1986	NULL
.	NULL

HTLV-1	NULL
associated	NULL
myelopathy	NULL
,	NULL
a	NULL
new	NULL
clinical	NULL
entity	NULL
.	NULL

Lancet	NULL
i:1031-1032	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
A.	NULL
F.	NULL
Gazdar	NULL
,	NULL
P.	NULL
A.	NULL
Bunn	NULL
,	NULL
J.	NULL
D.	NULL
Minna	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1980	NULL
.	NULL

Detection	NULL
and	NULL
isolation	NULL
of	NULL
a	NULL
type	NULL
C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:7415-7419	NULL
.	NULL

Pozzatti	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Vogel	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
fax	NULL
gene	NULL
can	NULL
cooperate	NULL
with	NULL
the	NULL
ras	NULL
oncogene	NULL
to	NULL
induce	NULL
neoplastic	NULL
transformation	NULL
of	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:413-417	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Ernst	NULL
,	NULL
1993	NULL
.	NULL

In	NULL
vivo	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IxBa	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4685-4695	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
M.	NULL
L.	NULL
MacKichan	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
has	NULL
IxB-like	NULL
functions	NULL
.	NULL

Cell	NULL
71	NULL
;	NULL
243-253	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Poteat	NULL
,	NULL
T.	NULL
H.	NULL
Tan	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
R.	NULL
Roeder	NULL
,	NULL
W.	NULL
Haseltine	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1988	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-1	NULL
tax	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
241:89-91	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
251:1490-1493	NULL
.	NULL

Salahuddin	NULL
,	NULL
S.	NULL
Z.	NULL
,	NULL
P.	NULL
Markham	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
G.	NULL
Franchini	NULL
,	NULL
V.	NULL
S.	NULL
Kalyanaraman	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1983	NULL
.	NULL

Restricted	NULL
expression	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia-lymphoma	NULL
virus	NULL
(	NULL
HTLV-1	NULL
)	NULL
in	NULL
transformed	NULL
human	NULL
umbilical	NULL
cord	NULL
blood	NULL
lymphocytes	NULL
.	NULL

Virology	NULL
129	NULL
;	NULL
51-64	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p65	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:733-736	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Rieber	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10	NULL
;	NULL
:2247-2258	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Muller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Scott	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
regulates	NULL
IB	NULL
by	NULL
two	NULL
distinct	NULL
mechanisms	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:1266-1276	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
sequences	NULL
.	NULL

Cell	NULL
46:705-716	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

88	NULL
.	NULL

89	NULL
.	NULL

90	NULL
.	NULL

91	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
N.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
interleukin	NULL
2	NULL
and	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
Tac	NULL
)	NULL
promoter	NULL
expression	NULL
by	NULL
the	NULL
transactivator	NULL
(	NULL
tat	NULL
)	NULL
gene	NULL
product	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:5389-5393	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
molecular	NULL
biology	NULL
of	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-I	NULL
)	NULL
and	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87:761-766	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1991	NULL
.	NULL

Type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
Tax	NULL
protein	NULL
transforms	NULL
rat	NULL
fibroblasts	NULL
through	NULL
the	NULL
cyclic	NULL
adenosine	NULL
monophosphate	NULL
response	NULL
element	NULL
binding	NULL
protein/activat-ing	NULL
transcription	NULL
factor	NULL
pathway	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88:1038-1042	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Rosen	NULL
,	NULL
W.	NULL
C.	NULL
Goh	NULL
,	NULL
and	NULL
W.	NULL
Haseltine	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
transcriptional	NULL
activator	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
x-lor	NULL
region	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Science	NULL
228:1430-1434	NULL
.	NULL

Stephens	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
R.	NULL
R.	NULL
Hiebsch	NULL
,	NULL
H.	NULL
R.	NULL
Bose	NULL
,	NULL
and	NULL
R.	NULL
V.	NULL
Gilden	NULL
.	NULL

1983	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
v-re/	NULL
:	NULL
the	NULL
oncogene	NULL
of	NULL
the	NULL
reticuloendotheliosis	NULL
virus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80:6229-6232	NULL
.	NULL

Steward	NULL
,	NULL
R.	NULL
1987	NULL
.	NULL

Dorsal	NULL
,	NULL
an	NULL
embryonic	NULL
polarity	NULL
gene	NULL
in	NULL
Droso-phila	NULL
,	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
vertebrate	NULL
proto-oncogene	NULL
,	NULL
c-rel	NULL
.	NULL

Science	NULL
238:692-694	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
IxBa	NULL
:	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregulatory	NULL
pathway	NULL
.	NULL

Science	NULL
259:1912-1915	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
C.	NULL
Béraud	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Autoregulation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transactivator	NULL
Rel	NULL
A	NULL
(	NULL
p65	NULL
)	NULL
by	NULL
multiple	NULL
cytoplasmic	NULL
inhibitors	NULL
containing	NULL
ankyrin	NULL
motifs	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:1346-1350	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
I.	NULL
Fujisawa	NULL
,	NULL
M.	NULL
Toita	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
trans-activator	NULL
tax	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-1	NULL
)	NULL
interacts	NULL
with	NULL
cAMP-responsive	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
binding	NULL
and	NULL
CRE	NULL
modulator	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
21-base-pair	NULL
enhancer	NULL
of	NULL
HTLV-1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:610-614	NULL
.	NULL

Tanaka	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Takahashi	NULL
,	NULL
S.	NULL
Yamaoka	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
M.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
Hatanaka	NULL
.	NULL

1990	NULL
.	NULL

Oncogenic	NULL
transformation	NULL
by	NULL
the	NULL
tax	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:1071-1075	NULL
.	NULL

Uchiyama	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Yodoi	NULL
,	NULL
K.	NULL
Sagawa	NULL
,	NULL
K.	NULL
Takatsuki	NULL
,	NULL
and	NULL
H.	NULL
Uchino	NULL
.	NULL

1977	NULL
.	NULL

Adult	NULL
T-cell	NULL
leukemia	NULL
:	NULL
clinical	NULL
and	NULL
hematologic	NULL
features	NULL
of	NULL
16	NULL
cases	NULL
.	NULL

Blood	NULL
50:481-492	NULL
.	NULL

Wagner	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
,	NULL
1993	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
protein	NULL
stimulation	NULL
of	NULL
DNA	NULL
binding	NULL
of	NULL
bZIP	NULL
proteins	NULL
by	NULL
enhancing	NULL
dimeriza-tion	NULL
.	NULL

Science	NULL
262:395-399	NULL
.	NULL

Wano	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Feinberg	NULL
,	NULL
J.	NULL
Hosking	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

Stable	NULL
expression	NULL
of	NULL
the	NULL
tax	NULL
gene	NULL
of	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
activates	NULL
specific	NULL
cellular	NULL
gene	NULL
involved	NULL
in	NULL
growth	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:9733-9737	NULL
.	NULL

Watanabe	NULL
,	NULL
M.	NULL
,	NULL
M.-A	NULL
.	NULL

Muramatsu	NULL
,	NULL
H.	NULL
Hirai	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
K.-I	NULL
.	NULL

Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1993	NULL
.	NULL

HTLV-I	NULL
encoded	NULL
Tax	NULL
in	NULL
association	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
precursor	NULL
p105	NULL
enhances	NULL
nuclear	NULL
localization	NULL
of	NULL
NF-kB	NULL
p50	NULL
and	NULL
p65	NULL
in	NULL
transfected	NULL
cells	NULL
.	NULL

Oncogene	NULL
8:2949-2958	NULL
.	NULL

Wilhelmsen	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
K.	NULL
Eggleton	NULL
,	NULL
and	NULL
H.	NULL
M.	NULL
Temin	NULL
.	NULL

1984	NULL
.	NULL

Nucleic	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
oncogene	NULL
in	NULL
reticuloendotheliosis	NULL
virus	NULL
strain	NULL
T	NULL
and	NULL
its	NULL
cellular	NULL
homolog	NULL
,	NULL
the	NULL
proto-oncogene	NULL
c-re/	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

§2	NULL
;	NULL
:172-182	NULL
.	NULL

Yodoi	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
Uchiyama	NULL
.	NULL

1992	NULL
.	NULL

Diseases	NULL
associated	NULL
with	NULL
HTLV-I	NULL
:	NULL
virus	NULL
,	NULL
IL-2	NULL
receptor	NULL
dysregulation	NULL
and	NULL
redox	NULL
regulation	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:405-411	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
Miyoshi	NULL
,	NULL
and	NULL
Y.	NULL
Hinuma	NULL
.	NULL

1982	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
retrovirus	NULL
from	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
and	NULL
its	NULL
implication	NULL
in	NULL
the	NULL
disease	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79:2031-2035	NULL
.	NULL

Zhao	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
C.	NULL
Z.	NULL
Giam	NULL
.	NULL

1991	NULL
.	NULL

Interaction	NULL
of	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-1	NULL
)	NULL
transcriptional	NULL
activator	NULL
Tax	NULL
with	NULL
cellular	NULL
factors	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
the	NULL
21-base-pair	NULL
repeats	NULL
in	NULL
the	NULL
HTLV-1	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:11445-11449	NULL
.	NULL

Zhao	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
C.	NULL
Z.	NULL
Giam	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-1	NULL
)	NULL
transcriptional	NULL
activator	NULL
,	NULL
Tax	NULL
,	NULL
enhances	NULL
CREB	NULL
binding	NULL
to	NULL
HTLV-1	NULL
21-base-pair	NULL
repeats	NULL
by	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7070-7074	NULL
.	NULL

